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Abstract 
Escherichia coli K12 serves as an important model for studying systems that are important 
to bacteria in their own right as well as those that are conserved in ‘higher' organisms, 
which are more difficult and costly to study. Like many model organisms, the genome of 
K12 has been sequenced, producing a catalogue of protein-coding and stable-RNA genes 
that enabled study using ‘omic’ approaches. This has led to a rapid expansion of our 
knowledge of patterns of gene expression and their dependency on growth conditions, cell 
physiology and individual genes. However, the underlying networks of gene regulation are 
less well understood, but are known to involve the control of steps in RNA processing and 
degradation as well as transcription and translation. With this in mind, this thesis describes 
the development of an approach based on RNA sequencing that produces nucleotide-
resolution transcriptome maps that distinguish sites that correspond to RNA processing 
and steps in degradation from those of transcription initiation, while incorporating all 
classes of RNA. Comparison with results obtained previously validated the approach, which 
has been applied already to the study of other bacterial species. Within the E. coli map, 
many new features were identified, such as previously undetected small RNAs and 
processing at a site associated with the production of specialised ribosomes, which may 
ensure the translation of leaderless mRNAs, which were also mapped. The approach also 
showed the benefit of incorporating steps that can differentiate the 5’ status of transcripts 
in assigning sites of transcription initiation. RNA sequencing was also used to map sites of 
cleavage by RNase E, an essential endoribonuclease that is central to both the processing 
and degradation of RNA in bacteria and plant plastids. This aspect of the thesis has 
advanced from pilot studies to the point where the ‘code’ that determines one form of 
substrate recognition by RNase E is beginning to emerge. As a result of this success, 
equivalent data has been collected for other ribonucleases involved in RNA processing and 
degradation. Continuing analysis of the primary and secondary transcriptomes, consisting 
of native, unprocessed transcripts and of transcripts that have been modified from their 
native form via processing and/or degradation respectively, with the tools presented here 
promises to broaden and deepen our understanding of an important model organism. 
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Chapter 1 
1 Introduction to RNA transcription and degradation 
1.1 Overview 
The Central “Dogma” of molecular biology, which is an explanation of the flow of genetic 
information (Crick, 1958; Crick, 1970), is often described as "DNA makes RNA makes 
protein" (Nirenberg, 2004). This particular description, which emphasises the role of 
transcription and translation, is an over simplification. It not only fails to include the flow of 
information from RNA to DNA through reverse transcription (Ahlquist, 2002), but also fails 
to describe the essential role of RNA processing in, for example, producing the RNA 
components of the translational machinery (Deutscher, 2009) and the critical role of mRNA 
degradation, which ensures that translation has to follow programming at the level of 
transcription (Dreyfus, 2009). 
Over the last decade, the study of gene regulation has made extensive use of microarrays 
to provide information on transcript levels on a genome-wide scale (Schena et al., 1995; 
Bier and Kleinjung, 2001; Goldsmith and Dhanasekaran, 2004). Such transcriptome data 
when available for different growth conditions, stages of development (for organisms that 
change morphology), and altered genetic backgrounds has allowed the identification of co-
expressed genes, which in turn has enhanced the identification of co-regulation (De Smet 
and Marchal, 2010; Storms et al., 2010). For example, numerous algorithms are available to 
identify sequences that are enriched upstream of co-regulated genes, and represent 
candidates for the binding of a shared transcription factor. Information on such cis-
regulatory sites is being collated in databases for organisms ranging from E. coli 
(RegulonDB) to humans (ENCODE) (The_Encode_Project_Consortium, 2004; Salgado et al., 
2006). With the obvious exception of splicing in eukaryotes, microarrays have provided 
scant information on the steps that control gene expression at the level of RNA processing 
and degradation. There are several main reasons for this, including insufficient resolution 
and sensitivity to detect processing and degradation intermediates and the inability to 
distinguish the pathways by which particular species are generated. However, these 
limitations no longer exist with the advent of RNA sequencing. 
This chapter provides an introduction to the control of gene expression in E. coli, with a 
particular emphasis on those processes that register an effect at the level of the RNA. It 
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starts by providing an overview of transcription initiation and its control, then moves on to 
describe RNA degradation and the various components involved in this process, placing 
specific attention on RNase E. It finally presents the sequencing approach that inspired the 
work presented in this thesis alongside the objectives and aims. The direct control of 
translation is covered, but only in relation to antisense RNA regulators. An overview of RNA 
sequencing is also provided. 
1.2 Transcription initiation 
As indicated above, gene expression is tightly regulated at several levels in all living 
organisms. One of these levels of regulation is the process of transcription. E. coli codes for 
a single RNA polymerase that is composed of four sub-units (β, β’ and two α subunits; 
α2ββ’). In order to recognise specific promoter sequences, a sigma factor (σ) must be 
associated with this α2ββ RNA polymerase core to yield a holoenzyme (Eσ) which can 
initiate transcription (Browning and Busby, 2004). 
 Sigma factors 1.2.1
E. coli has 7 sigma factors (Table 1.1) that are grouped into two main families, based on 
their evolutionary relatedness and their gene targets (Wösten, 1998; Buck et al., 2000; 
Browning and Busby, 2004; Sharma and Chatterji, 2010). These sigma factors work in 
conjunction within the cell and compete to bind RNA polymerase, with which they bind 
with a range of affinities. The first family belong to the E. coli σ70–type sigma factors (the 
number denotes mass in kDa), which are evolutionarily conserved in all bacteria and 
regulate most of the housekeeping genes throughout the bacterial life cycle (Gruber and 
Gross, 2003) as well as most genes during bacterial exponential growth (Buck et al., 2000; 
Browning and Busby, 2004; Sharma and Chatterji, 2010). In addition, extra cytoplasmic 
function (ECF) sigma factors, which are responsible for switching on the expression of 
genes involved in environment stress responses also belong to this family (Helmann, 2002; 
Brooks and Buchanan, 2008; Ho and Ellermeier, 2012). The second family corresponds to 
the σ54–type sigma factors, which share no homology with σ70 and in addition to the core 
α2ββ’ complex require ATP and enhancers to form a holoenzyme (Gruber and Gross, 2003). 
The latter group is involved mainly in the regulation of genes related to nitrogen 
metabolism (Buck et al., 2000). Whilst there are multiple representatives of the σ70 family 
per organism, the presence of more than one σ54 is rare (Wösten, 1998; Buck et al., 2000; 
Sharma and Chatterji, 2010). Also, worth mentioning is that an additional level of 
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regulation is achieved by sigma factor antagonists known as anti-sigma factors (Hughes and 
Mathee, 1998). 
Name Consensus sequence Binding affinity 
  −35 Spacer −10 Kd (nM) 
σ70-family 
σ70, (σD) TTGACA 16–18 TATAAT 0.26 
σ38, (σS) N/D N/D CTATACT 4.26 
σ32, (σH) CTTGAAA 11–16 CCCATNT 1.24 
σ28, (σF) TAAA N/D GCCGATAA 0.74 
σ24, (σE)* GAACTT 16–17 TCTRA 2.43 
σ19, (σFECI)* N/D N/D N/D 2.43 
σ54-family 
  −24 Spacer −12 
 σ54, (σN) TGGCAC N/D TTGCW 0.3 
Table 1.1 - Sigma factors in E. coli. Table presenting the sigma factors of E. coli alongside 
the consensus sequences they recognize relative to the site of transcription initiation, the 
spacer length between the consensus sequences and the binding affinity of each sigma 
factor to RNA polymerase. ECFs are indicated with an *. N = any base, R = A or G and W = A 
or T N/D=Not determined. This table was adapted from two publications (Wösten, 1998; 
Sharma and Chatterji, 2010).  
 Consensus sequences involved in transcription initiation 1.2.2
Sigma factors are essential for basal transcription initiation; thus, knowledge of the specific 
sequences, known as consensus sequences, that each of them recognise when assembled 
into a holo-RNA polymerase is essential if the regulation of gene expression is to be 
understood and modelled. Consensus sequences have been determined for sigma factors 
in E. coli. For example, the consensus sequences for σ70 are TATAAT, centred at position -10 
(relative to site of transcription initiation) and TTGACA at position -35 (Hook-Barnard et al., 
2006) whilst the consensus sequences for σ54 are TGGCA, centred at position -24 and TTGC 
at position -12. The particular sequence bound by a sigma factor has a major impact on the 
rate of transcription initiation. Indeed, the better the match between a promoter sequence 
and the consensus sequence for the sites recognised by a sigma factor, the stronger the 
promoter (Ishihama, 1990; Kobayashi et al., 1990). 
 Role of transcription factors 1.2.3
In addition, the rate of transcription initiation can be further regulated by a set of proteins 
referred to by bacteriologists as transcription factors (TFs). In general TFs, bind to specific 
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sites in the vicinity of promoters and make contacts with RNA polymerase, thereby altering 
its ability to initiate transcription. Activators promote the binding of RNA polymerase and, 
as a result, the initiation of transcription. On the other hand, repressors prevent the 
binding or progression of RNA polymerase, thus inhibiting transcription. Overall, in E. coli 
there are over 270 genes that have been suggested to code TFs (Madan Babu and 
Teichmann, 2003). Only about half have been characterized experimentally, and of these 
TFs the consensus sequences (or knowledge of the contribution of individual nucleotide 
positions to binding) of only 172 are currently logged in RegulonDB (Salgado et al., 2006).  
1.3 RNA degradation 
 Introduction 1.3.1
Another level of gene regulation occurs when RNA is processed and degraded, which is the 
main area of research in the McDowall laboratory and of central importance for the 
development of the project here presented. The degradation of RNA provides the 
counterbalance to transcription and enables the translational machinery to follow closely 
programs of transcription. Furthermore, there is a close interplay between translation and 
mRNA decay as the translational machinery is known to protect mRNA from decay (Iost and 
Dreyfus, 1995; Joyce and Dreyfus, 1998; Dreyfus, 2009). This means that the effects of 
translation will affect mRNA decay and register at the RNA level. 
 
In E. coli, which is the major model system for studying post-transcriptional control in 
bacteria, RNA is degraded by the combined action of endonucleases and 3’ to 5’ 
exonucleases, which function in concert with helicases, poly(A) polymerase, an RNA 5’ 
pyrophosphohydrolase (or ‘decapping’ enzyme) and protein regulators (Carpousis et al., 
2009). Endonucleolytic cleavage is thought to accelerate the degradation of E. coli mRNA 
(or at least segments) by allowing 3’ exonuclease access either prior to the termination of 
transcription or transcriptional terminator structures at the 3’. The generally accepted 
model for RNA degradation is presented in Figure 1.1. 
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Figure 1.1 - Endonucleolytic RNA degradation model. (A) Polyribosomal RNA is cleaved at 
AU rich areas by RNase E (Mcdowall et al., 1994; Mcdowall and Cohen, 1996). (B) The 
resulting RNA fragments are digested into single nucleotides by the combined action of 
exonucleolytic enzymes such as PNPase, RNase R and helicase RhlB (Carpousis et al., 2009). 
Oligoribonuclease is a 3’ to 5’ processive RNase and degrades partially degraded RNAs to 
monoribonucleotides. The RNA degradosome, a multi-component complex in E. coli, is 
composed of RNase E, PNPase, RhlB and enolase (Taghbalout and Rothfield, 2008; 
Carpousis et al., 2009); enzymes that form part of the degradosome are highlighted in 
brown and marked with an asterisk. Taken from (Carpousis et al., 2009). 
 Ribonucleases 1.3.2
As mentioned above, RNA in E. coli is degraded and matured by the concerted action of 
endoribonucleases and 3’ to 5’ exoribonucleases. In E. coli, there is no evidence for a 5’ to 
3’ exoribonuclease, although one does exist in B. subtilis and other bacteria (Even et al., 
2005; Madhugiri and Evguenieva-Hackenberg, 2009; Bugrysheva and Scott, 2010). 
Endoribonucleases cleave within the RNA strand, similar to the cleavage of DNA by 
restriction enzymes, but without the same stringent sequence specificity. Much work has 
focused on RNase E as its inactivation leads to the stabilisation of most transcripts in E. coli, 
as well as blocking processing of tRNA (Ow and Kushner, 2002) and rRNA (Apirion and 
Lassar, 1978; Ono and Kuwano, 1979). Other important endoribonucleases are RNase III, 
RNase P, RNase G and MazF. On the other hand, exoribonucleases digest the RNA strand 
from the 3’ to the 5’ end of the transcript and remove one nucleotide at a time. The main 
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representatives of this group with regard to the degradation of mRNA are RNase II, RNase R 
and PNPase. Exonuclease RNase Z is also worth mentioning, as it is responsible for the 
processing of the 3’ end of tRNAs. For a full list of exo- and endo-ribonucleases, along with 
their role in RNA processing and degradation, refer to Table 1.2. Exoribonucleases can 
either be distributive (will dissociate from the RNA strand after each individual nucleotide is 
removed) or processive (remain associated with the substrate until the phosphodiester 
bond upstream of the last removable nucleotide has been cleaved). PNPase is a 
phosphorolytic enzyme that produces nucleotide diphosphates, while RNase II and RNase R 
are hydrolytic and produce nucleotide monophosphates (Carpousis et al., 2009). The fact 
that PNPase activity generates nucleotide diphosphates and RNase II and RNase R generate 
nucleotide monophosphates is important for energy conservation and the generation of 
ATP. Ribonuclease activity is not the only function that aids in the degradation of RNA; 
indeed, polyadenylation, catalysed by poly(A) polymerase, causes the 3’ terminus of RNA to 
become more susceptible to 3’ exonucleolytic attack with as little as 5 adenosine residues 
added (Blum et al., 1999). Furthermore, PNPase is also known to function in reverse in 
order to add heterooligomeric tails which could promote 3’ to 5’ exonucleolytic attack 
(Mohanty and Kushner, 2000).
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Enzyme 
Exo or Endo-
ribonuclease 
Role in RNA metabolism  
Sigma 
factor* 
Reference 
PNPase Exo 3’ tRNA processing and mRNA decay 70  (Soreq and Littauer, 1977; Littauer and Soreq, 1982) 
RNase R Exo rRNA maturation, mRNA degradation  ND  (Cheng et al., 1998) 
RNase PH Exo 3' tRNA processing ND  (Deutscher et al., 1988; Mian, 1997; Zhou and Deutscher, 1997) 
RNase II Exo 3' tRNA processing 70  (Gupta et al., 1977) 
RNase D Exo 3' tRNA processing 70  (Cudny et al., 1981; Mian, 1997) 
RNase T Exo 3' tRNA processing and 5S rRNA 3' maturation 24  (Deutscher and Marlor, 1985) 
Oligo-RNase Exo Processive 3' to 5' RNase 70  (Niyogi and Datta, 1975; Zhang et al., 1998) 
RNase III Endo 5S, 16S and 23S rRNA precursor formation  70  (Robertson et al., 1967; Conrad et al., 2002) 
RNase P Endo 5' tRNA processing 70  (Pace and Brown, 1995) 
RNase Z Endo tRNA processing 70  (Callahan et al., 2000; Ezraty et al., 2005) 
MazF Endo mRNA processing and degradation 70 
 (Christensen et al., 2003; Zhang et al., 2003; Munoz-Gomez et al., 
2004) 
RNase E Endo 5S, 16 S and 23S rRNA maturation and mRNA decay 70  (Ghora and Apirion, 1978; Ono and Kuwano, 1979) 
RNase G Endo 16S rRNA 5' maturation and mRNA decay  N/D  (Mcdowall et al., 1993; Wachi et al., 1999; Tock et al., 2000) 
RNase I Endo 23S RNA and total mRNA degradation  N/D 
 (Cannistraro and Kennell, 1989; Meador and Kennell, 1990; 
Cannistraro and Kennell, 1991; Subbarayan and Deutscher, 2001) 
RNase LS Endo Bacteriophage T4 and cellular mRNA degradation 70/32  (Otsuka et al., 2003; Otsuka and Yonesaki, 2005) 
RNase HI Endo RNA degradation in RNA-DNA hybrids 24  (Mian, 1997) 
RNase HII Endo RNA degradation in RNA-DNA hybrids 24   (Mian, 1997) 
Table 1.2 - List of exo and endo-ribonucleases in E. coli. This table presents all of the known E. coli ribonucleases along with their role in RNA metabolism 
and the sigma factors that regulate their transcription. Note that 70 is responsible for mediating the transcription of most ribonucleases. Adapted from 
(Condon, 2007) and (Gutgsell and Jain, 2010). *Data from RegulonDB if present. RNases which are part of toxin-antitoxin systems are not included with the  
exception of MazF (N/D= not determined).
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 RNase E 1.3.3
In E. coli, the rapid degradation of mRNA is known to be highly dependent on RNase E. This 
endoribonuclease is required for the normal, rapid degradation of many, if not most 
transcripts (for recent reviews, see (Deutscher, 2006; Carpousis et al., 2009)) , including 
RNAI, the antisense RNA regulator of ColEI-type plasmid replication (Tomcsanyi and 
Apirion, 1985; Lin-Chao and Cohen, 1991). It also has a role in the processing of precursors 
of ribosomal RNA (Ghora and Apirion, 1978; Misra and Apirion, 1979; Li et al., 1999b) and 
transfer RNA (Li and Deutscher, 2002; Ow and Kushner, 2002) as well as several other small, 
non-protein-coding RNAs (Lundberg and Altman, 1995; Lin-Chao et al., 1999). Concordant 
with its central role in RNA processing and degradation, RNase E is essential for E. coli 
viability (Apirion and Lassar, 1978; Ono and Kuwano, 1979). It is known that the inactivation 
of rne leads to the accumulation of a large rRNA precursor (unprocessed 17 S rRNA) (Li et 
al., 1999a)and the 9S precursor of 5S rRNA (Ghora and Apirion, 1978). RNase E is assisted in 
the processing of 16S rRNA by a paralogue called RNase G (Li et al., 1999b; Wachi et al., 
1999); which is also required for the normal degradation of several functional transcripts 
(Wachi, 2001; Lee et al., 2002; Jourdan and Mcdowall, 2008). 
1.3.3.1 Regulation and role in RNA degradation 
RNase E plays a central role in the widely accepted RNA degradation model (Figure 1.1). 
Despite this model being widely acknowledged, inactivation of rne in E. coli does not 
abolish mRNA degradation but only slows it down (Ono and Kuwano, 1979; Lee et al., 
2002). This suggests that, despite being essential for cell viability, the role of RNase E in 
mRNA processing and degradation might be fulfilled by other enzymes; for example, its 
paralogue RNase G. RNase E shares with RNase G a high N-terminal catalytic domain 
sequence similarity and the ability to process 16S rRNA, as well as high specificity for 5’-
monophosphorylated RNA, due to both enzymes having a 5’-monophosphate sensing 
pocket (Mcdowall and Cohen, 1996). Furthermore, the activity of RNase E is tightly 
regulated in the cell by a variety of mechanisms. RNase E can auto regulate the level of its 
own transcript by controlling the decay of its mRNA and adjusts its synthesis according to 
the levels of its substrates (Mudd and Higgins, 1993; Jain and Belasco, 1995; Sousa et al., 
2001) In addition, RNase E can be inhibited by direct binding of the inhibitor proteins RraA 
and RraB (Gao et al., 2006; Gorna et al., 2010). Antisense RNAs are capable of blocking or 
enhancing translation and mRNA degradation. This means, RNase E activity can be affected 
by sRNAs, which can act passively or actively on specific mRNA targets. In the first case, 
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translation is silenced or sites are made available for RNase E cleavage by the direct binding 
of sRNAs to the mRNA (Lease et al., 1998; Morita et al., 2006; Darfeuille et al., 2007; Maki 
et al., 2008; Pfeiffer et al., 2009). In the second case, sRNAs generate complexes with the 
chaperone Hfq in order to recruit specific mRNAs to RNase E and thus stimulate their 
degradation (Massé et al., 2003; Morita et al., 2005; Pfeiffer et al., 2009; Vogel and Luisi, 
2011). An example of the latter is the MicC-Hfq RNase E mediated degradation of ompD 
(Pfeiffer et al., 2009). Other components of the degradosome are also regulated, for 
example PNPase activity is known to be modulated by citrate (Nurmohamed et al., 2011). 
Models that do not depend on endonucleolytic cleavage of the RNA strand by enzymes 
such as RNase E as the initial step of degradation should be further explored. Indeed, the 
existence of RppH, a 5’ pyrophosphatase, suggests that there might be a complementary 
pathway for RNA degradation in which RppH converts triphosphate groups at the 5’ end of 
nascent transcripts (which protect RNA from degradation), into 5’-monophosphate groups. 
This would render the RNA susceptible to 5’-monophosphate dependent ribonucleases, 
including RNase E (Deana et al., 2008). 
1.3.3.2 Structure of RNase E 
RNase E is an enzyme of two halves (Figure 1.2). The N-terminal half (NTH) provides the 
endonucleolytic activity (Mcdowall and Cohen, 1996; Callaghan et al., 2005; Caruthers et 
al., 2006), while the C- terminal half (CTH) provides contacts that allow the formation 
(Vanzo et al., 1998; Callaghan et al., 2004; Carpousis et al., 2009) and cellular localisation 
(Khemici et al., 2008) of the degradosome complex. RNase G is related in sequence to only 
the NTH of RNase E (Mcdowall et al., 1993). The NTH of RNase E forms a tetramer 
(Callaghan et al., 2003), which is a dimer of the dimeric unit that forms the active sites 
(Callaghan et al., 2005). The CTH of RNase E contains ancillary RNA-binding sites 
(Taraseviciene et al., 1995; Mcdowall and Cohen, 1996; Kaberdin et al., 2000) and segments 
that facilitate interaction with the inner membrane (Miczak et al., 1991; Liou et al., 2001; 
Khemici et al., 2008) and with RhlB, enolase and PNPase which come together to form an 
RNA processing and degradation complex called the RNA degradosome (Figure 1.3) (for 
reviews, see (Carpousis et al., 2001; Carpousis, 2002; Marcaida et al., 2006; Carpousis et al., 
2009). E. coli strains that have the CTH of RNase E have a competitive growth advantage 
over those where this region has been deleted. The CTH also aids in the degradation of 
highly structured RNAs, which accumulate in CTH deletion strains.(Mackie, 2013b). 
Furthermore, the CTH of RNase E plays a vital role in processing and degradation in vivo as 
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strains that contain RNase E where the 5’-monophosphate sensing pocket has been 
inactivated or deletion of RppH together with truncation of the CTH are not viable 
(Anupama et al., 2011). Nevertheless, only the NTH of E. coli RNase E is required for cell 
viability (Apirion and Lassar, 1978; Ono and Kuwano, 1979). 
 
Figure 1.2 – Schematic representation of the primary structure of RNase E and 
components of the degradosome. The catalytic region of RNase E (NTH) spans residues 1-
529. Residues 530-1061 correspond to the C- terminal half of the enzyme, which has 
several functional segments that enable RNase E to engage in protein-protein interactions 
(Carpousis et al., 2009) including with RhlB (residues 698-762). The segments labelled as A, 
B, C and D are regions that are known to: i) localize the degradosome to the cellular 
membrane, ii) form a coil-coil motif and an arginine rich RNA binding domain (RBD) iii) bind 
enolase and iv) bind PNPase, respectively.(Carpousis et al., 2009). Regions of the CTH 
involved in intermolecular interactions are labelled dark blue whilst highly structured 
regions are presented in orange. Adapted from (Carpousis et al., 2009). 
 
Figure 1.3 – Schematic representation of the RNA degradosome in E. coli. This figure 
represents the degradosome; PNPase (blue) has been cross-sectioned to illustrate the 
active site. It can be seen that the RNA is presented to PNPase in an unwound conformation 
as RhlB (green) unwinds the RNA’s stem loop (red) which would otherwise provide the RNA 
with ribonucleolytic protection. Both PNPase and RhlB are associated with RNase E (dark 
blue). Enolase and other components of the degradosome were removed for simplicity. 
Adapted from (Bandyra and Luisi, 2013). 
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1.3.3.3 5’ monophosphate sensing by RNase E 
The ability of RNase E to sense RNA 5’ end structures in vivo (Bouvet and Belasco, 1992) 
results in a repertoire of transcripts incorporating secondary structures to their 5’ end in 
order to grant them increased stability. Indeed, two mechanisms, which provide RNA 
transcripts with increased protection against RNA degradation, have been identified. Firstly, 
the concealment of the 5’ ends by either adding a 5’ stem-loop or circularizing the RNA. The 
presence of a 5’ stem-loop has been shown to give ompA mRNA (Emory et al., 1992) great 
stability. This transcript has a half-life of 15-20 min and has been shown to be amongst the 
most stable mRNAs in E. coli (Von Gabain et al., 1983); this feature is also shared with RNAI 
(Bouvet and Belasco, 1992). RNA circularization has also been shown to stabilize rpsT mRNA 
(Mackie, 2000; Baker and Mackie, 2003). Secondly, the 5’-triphosphate group or ‘cap’ 
incorporated during transcription has also been shown to stabilize transcripts. Initial 
observations showed that RNase E cleavage rates for rpsT mRNA and the 9S precursor of 5S 
rRNA in vitro were significantly greater when the 5′ end possessed a 5’-monophosphate 
group in contrast to when they had a 5’-triphosphate group (Mackie, 1998).  
Following the studies described above, the X-ray crystal structure of the N-terminal half of 
RNase E complexed with oligonucleotide substrates lacking any 5’ end protective features 
(corresponding to the segment cleaved at the 5’ end of RNAI) was solved. This structure 
revealed a binding pocket for 5′ ends that terminate in a 5’-monophosphate group and 
have at least 3-5 unpaired nucleotides (Figure 1.4). Transcripts which have a 5’-
monophosphate group are contacted by a semi-circular ring of hydrogen bonding donors 
created by the side chain and peptide amide of Thr170 and the guanidino group of Arg169; 
the terminal base is contacted via a hydrophobic interaction with the side chain of Val128 
(Callaghan et al., 2005). The interaction of Arg169 is consolidated by a hydrogen bond to 
the peptide backbone of Gly124 in the neighbouring strand of the sensor. As there is 
insufficient room in the pocket to accommodate a 5’ end that has a triphosphate group or 
is base-paired, the pocket can only bind a 5’-monophosphorylated, single stranded end. 
Residues in this pocket have been mutated in both E. coli RNase E and RNase G (Jourdan et 
al., 2009; Kime et al., 2010). The RNase E mutant, T170V, shows a notable reduction in its 
ability to cleave 5’-monophosphorylated oligonucleotide substrates, but still retains its 
basal activity for the cleavage of 5’-hydroxylated oligonucleotide substrates (Kime et al., 
2010). 
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Figure 1.4 - The binding pocket for 5’-monophosphorylated ends in RNase E. This figure 
shows the interactions that take place between the 5’-monophosphate group in the RNA 
and RNase E. The monophosphate group is held in place by three hydrogen bonds 
(represented as dotted lines). An additional hydrogen bond is formed between R169 and 
G124 within RNase E in order to support the interaction between R169 and the 5’-
monophosphate group. Another important interaction that stabilizes this complex is that of 
V128 and the aromatic ring in the RNA terminal base; an interaction that is modified in the 
T170V mutant, making it insensitive to the presence of 5’-monophosphorylated ends. 
Adapted from (Callaghan et al., 2005). 
1.3.3.4 Stimulation of RNase E activity via RppH mediated ‘decapping’ 
Structural studies aided in the elucidation of the preference of RNase E for 5’-
monophosphorylated substrates (Tock et al., 2000; Callaghan et al., 2005). Nevertheless, 
the mechanism by which 5′ stem-loops provided protection against RNase E-mediated 
degradation in vivo (Bouvet and Belasco, 1992; Baker and Mackie, 2003) was still unclear as 
primary transcripts are synthesised with a 5′ triphosphate group. This was recently 
elucidated with the discovery, in E. coli, of an RNA pyrophosphohydrolase (RppH). RppH 
converts the primary 5′ triphosphate group to a 5’-monophosphate group (Celesnik et al., 
2007; Deana et al., 2008). 
Upon inactivation of RppH in vivo, the half-lives of a range of mRNAs were studied and 
were found to increase considerably; up to fourfold for rpsT. This observation confirmed 
the importance of RppH in the generation of 5’-monophosphate single stranded ends under 
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physiological conditions (Deana et al., 2008). Nevertheless, when assessed on a genome-
wide scale, the majority of transcripts in E. coli seemed to be largely unaffected by 
inactivation of RppH (Deana et al., 2008). Thus 5’ ‘decapping’ does not appear to be 
essential for rapid mRNA degradation. This observation is possibly due to RNase E not 
requiring an interaction with 5’-monophosphate ends to in order to make initial cuts in the 
RNA (see section 1.3.3.5). 
1.3.3.5 Direct entry by RNase E 
Consistent with the idea that RNase E can cleave independently of the 5’ end it has been 
found recently that the NTH of both wild-type RNase E and the T170V mutant can rapidly 
cleave cspA mRNA in vitro without requiring a 5’-monophosphorylated end (Kime et al., 
2010). Moreover, using a well-characterised oligonucleotide substrate, a minimum 
requirement for cleavage was determined in which the presentation of multiple single-
stranded segments allows their simultaneous interaction with RNase E and enhanced 
cleavage (Kime et al., 2010). In addition, RNase E has been shown to process a tRNA 
precursor in vitro by binding single stranded regions that are adjacent but not contiguous to 
the site that is cleaved (Kime et al., 2014). Single-stranded segments are abundant in RNA, 
thus direct entry could represent a major mechanism by which mRNA degradation and 
processing is initiated by RNase E in E. coli and other RNase E homologue containing 
organisms. Furthermore, the above observations suggest that direct entry might be the 
preferred mechanism of 5‘-triphosphorylated RNA cleavage, a mechanism which is 
enhanced by the ability of RNase E which is a tetramer to bind multiple single stranded 
regions. 
 RNA stability 1.3.4
RNA can be categorized into two groups based upon its turnover rate; “stable” RNA, such as 
tRNA and rRNA, which have half-lives in the order of tens of minutes (Curnow et al., 1993) 
and “unstable” RNA, such as the majority of mRNA. The half-life of total mRNA has been 
estimated to be 6.8 min, with some mRNAs having a half-life of under 40 sec (Selinger et al., 
2003). In the case of the latter, it is likely that translation is limited to the passage of only a 
single ribosome per transcript. It has been reported that there is some correlation between 
half-lives and the function encoded by the transcript, e.g. transcripts encoding enzymes of 
central metabolism tend to have longer half-lives than those encoding products of 
unknown function (Selinger et al., 2003); these short half-lives make it difficult to 
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characterize and study such mRNAs. These findings reiterate the fact that mRNA decay is a 
crucial step in regulating the expression of specific genes and of the need for high 
throughput methods to better understand the global code required for the degradation of 
mRNA. 
1.4 Previous RNA sequencing approach 
Microarrays have been extensively used in order to study the expression of thousands of 
genes in parallel in a variety of organisms (Bier and Kleinjung, 2001). They have also been 
implemented to elucidate the response and regulation of the transcriptome to 
environmental stresses. They have provided a methodology reaching further than that 
which was achievable by previous technologies such as nuclease mapping (Weaver and 
Weissmann, 1979) and primer extension (Shelness and Williams, 1985). Despite the density 
of probes increasing in recent years to give a coverage of up to 3 Mbp (approximately every 
10 bp), this approach is still incapable of providing nucleotide resolution maps of primary or 
secondary transcriptomes (Goldsmith and Dhanasekaran, 2004). At present, the only way to 
achieve single-nucleotide resolution maps is through global RNA sequencing (gRNA-seq); 
often referred to as transcriptome shotgun sequencing (Mamanova and Turner, 2011). 
Recently, the primary transcriptome of the major human pathogen Helicobacter pylori has 
been sequenced with an RNA-seq approach described in Figure 1.5 (Sharma et al., 2010). 
This approach was a genome-wide RNA-ligase mediated, reverse transcription PCR. The 
method depleted the transcriptome of 5’-monophosphorylated RNA by treating total RNA 
with Terminator™ 5’ phosphate-dependent exonuclease (TEX). The remaining 5’-
triphosphorylated RNA was treated with a pyrophosphatase in order to generate 5’-
monophosphorylated ends and these were then cloned, sequenced and mapped onto the 
genome to identify transcription start sites. This technology had two major limitations. 
Firstly, it removed the secondary transcriptome and any information regarding processing; 
secondly, it used the Roche-454 sequencing technology that provides a lower number of 
reads than the Illumina technology.  
Whilst the work of Sharma et al. (2010) inspired the work here presented, modifications 
were made in order to adapt and enhance the capability of this approach. These 
modifications were made in order to increase the sequencing depth and secondly, detect 
and map the secondary transcriptome of E. coli (Figure 1.5). 
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Figure 1.5 - The sequencing approach of Sharma et al. (2010) and our sequencing 
approach. The sequencing approach undertaken by Sharma et al. (2012) is highlighted grey. 
Total RNA was extracted from H. pylori and separated into two aliquots; a control and a 
sample which was depleted of 5’-monophosphate ends (processing sites) with TEX. The 5’-
triphosphorylated RNA in both samples was then treated with a pyrophosphatase in order 
to generate 5’-monophosphorylated ends and then ligated to a 5’ adaptor. This was 
followed by the generation of cDNA libraries and sequencing, performed using a Roche 454 
platform (Sharma et al., 2010). The sample treated with TEX was enriched for TSSs and the 
control sample contained both processing sites and TSSs. Our sequencing approach made 
use of dRNA-seq (highlighted green) and gRNA-seq (highlighted blue). The dRNA-seq was 
performed in a similar way to Sharma et al. (2010) with three main differences. Firstly TAP 
was used to treat the non-control sample, instead of TEX. This enriched TSSs and, unlike 
TEX, did not remove products of processing and degradation. Secondly, RNA was 
fragmented prior to 3’ end adaptor ligation in order to allow the sequencing of both long 
and short transcripts. The third difference was that Illumina sequencing was used instead of 
Roche 454 sequencing, as it is more adequate for the sequencing of shorter transcripts. In 
addition to these differences, our approach also included gRNA-seq (Mamanova et al., 
2010) in which we fragmented and sequenced every transcript present in the cells. 
 
16 
 
1.5 Broad objective and specific aims 
The broad objective of this thesis was to develop approaches that would provide, for the 
first time, a transcriptome-wide view of steps in RNA processing and decay, with focus on 
the role of direct-entry cleavage by RNase E. The specific aims were to (i) confirm that 
treatment with TAP could be used to provide efficient discrimination of the 5’ 
phosphorylation status of transcripts (Chapter 3), (ii) confirm that the T170V substitution of 
RNase E reduces the efficiency of 5’-monophosphate-dependent cleavage, without 
affecting the efficiency of 5’-monophosphate-independent cleavage (Chapter 3), (iii) 
prepare samples of total RNA digested with T170V and perform RNA–sequencing to 
identify sites of cleavage in vitro (Chapter 3 and Chapter 4), (iv) in parallel with (iii), analyse 
the transcriptional landscape of E. coli using FRT RNA-seq, an improved global approach, in 
conjunction with a differential RNA-seq approach that retains products and intermediates 
of RNA processing and decay (Chapter 4), (v) identify sites of direct entry cleavage that 
occur in vivo as well as in vitro (Chapter 4), and (vi) validate experimentally any novel 
features identified within the transcriptional landscape of E. coli (Chapter 5). Overall, the 
specific aims were met, but further experiments by others were required to confirm that 
cleavages produced by T170V were indeed independent of 5’-monophosphate sensing.
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Chapter 2  
2 Materials and Methods 
2.1 Bacterial strains and media 
Strains and plasmids used are listed in Table 2.1. E. coli cells were grown at various 
temperatures, which are indicated as appropriate. Cells were grown in Luria Bertani 
medium: 1% (w/v) tryptone, 0.5% (w/v) NaCl, and 0.5% (w/v) yeast extract (Sigma Aldrich). 
When needed, selective growth conditions were achieved by adding carbenicillin or 
kanamycin to a final concentration of 50 µg/ml. All media were autoclaved for 20 min at 
121 psi prior to use. Heat-sensitive components such as antibiotics were sterilized by 
filtration through 0.2 µm disposable filters (Sarstedt GmbH) and added after heat 
sterilization of the other components. Plates were prepared by adding 1.5% (w/v) of agar 
(Sigma Aldrich) to liquid medium prior to autoclaving. Aeration of 50 ml liquid cultures was 
achieved by continuous shaking at 220 rpm in 250 ml Erlenmeyer flasks. Strains were 
stored at –80°C as glycerol stocks: 50% (v/v) glycerol and 50% (v/v) overnight culture. 
Strains Description Source 
BW25113 
 
F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, rph-
1, Δ(rhaD-rhaB)568, hsdR514 
 
Keio collection 
(Baba et al., 
2006) 
JW2753  
 
As BW25113, but ΔchpA781::kan 
 
Keio collection 
(Baba et al., 
2006) 
N3433 Hfr(PO1), lacZ43 (FS), λ-, relA1, spoT1, thiE1 (Browning and 
Busby, 2004) 
N3431 As N3433, but rne-3071(ts) (Browning and 
Busby, 2004) 
JM109 endA1, recA1, gyrA96, thi, hsdR17 (rk
–, mk
+), relA1, 
supE44, Δ(lac-proAB), [F´ traD36, proAB, 
laqIqZΔM15] 
Promega 
(Sharma and 
Chatterji, 2010) 
Table 2.1 - Strains. This table lists all strains used in this thesis alongside a description and 
indication of their source. 
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2.2 Gel electrophoresis 
 Agarose gel electrophoresis 2.2.1
DNA was separated according to its size using agarose gel electrophoresis. Protocols were 
based on (Sambrook, 2001). The agarose concentration (w/v) varied depending on the size 
range of the fragments that were analysed and is stated within the corresponding figure 
legends. Agarose (Melford) was dissolved in 1 x TBE: 89 mM Tris-HCl (pH 8.3), 89 mM boric 
acid, and 2 mM EDTA. Samples were loaded in 1 x DNA loading dye: 10 mM EDTA (pH 8), 
10% (v/v) glycerol, 0.06% (w/v) Bromophenol Blue (Ambion). DNA markers (Fermentas) 
were used as size standards. Electrophoresis was performed at 10Vcm-1 of gel for 60 min. 
Gels were stained by soaking for 30 min in 1 x TBE containing 1 µg/ml ethidium bromide 
and imaged with the use of a GeneGenius UV transilluminator (Syngene) set at an 
excitation wavelength of 302 nm. 
 Polyacrylamide gel electrophoresis 2.2.2
Polyacrylamide gel electrophoresis was used to separate both RNA and DNA samples by 
size. In order to separate RNA, denaturing polyacrylamide gels composed of 19:1 
polyacrylamide: bis-acrylamide in 7 M urea and 1 x TBE were used. The concentrations of 
acrylamide are stated in the corresponding figure legends. DNA was similarly separated, 
except urea was omitted from the gels. For RNA gels, markers and 2 x denaturing loading 
dye from Ambion were used, while for DNA gels, the marker and loading dyes were those 
used for agarose gel electrophoresis. Gels were typically run for ~2200 Vh. 
 SDS gel electrophoresis  2.2.3
SDS-PAGE was performed as previously described (Laemmli, 1970). Gels contained a 
stacking and a running layer of 4 % (w/v) and 18 % (w/v) acrylamide: bis-acrylamide (29:1, 
Severn Biotech), respectively. Gels were run in 1 x electrophoresis buffer: 0.1 % SDS (w/v), 
25 mM Tris base, 192 mM glycine (Sigma Aldrich) at 25 mA for 1-2 h. Gels were stained by 
soaking in Coomassie stain: Coomassie Brilliant Blue R-250 (150 mg l-1) in 25 % (v/v) 
ethanol, 10 % (v/v) acetic acid (Sigma Aldrich). Gels were destained by soaking in destain 
solution: 40 % (v/v) methanol, 10 % (v/v) acetic acid (Sigma Aldrich). Imaging was 
performed in a GeneGenius UV transilluminator (Syngene) with lower white light settings. 
Samples were denatured in 2 x Laemmli buffer: (4% SDS, 20% glycerol, 10% 2-
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mercaptoethanol, 0.004% bromophenol blue and 0.125 M Tris HCl, pH approx. 6.8) (Sigma 
Aldrich) for 5 min at 99 °C prior to loading. 
2.3 Radio-labelled probe generation 
Specific transcripts were probed using complementary oligonucleotides (see Table 2.2) 
labelled at their 5’ ends with 32P using T4 polynucleotide kinase (Thermo Scientific) and γ-
32P-ATP (3000 Ci mmol-1 10 mCi mL-1, 250 µCi, Perkin Elmer). The labelling reaction was 
carried at 37°C for 30 min and stopped by the addition of EDTA, both as described by the 
vendor of the enzyme (Thermo Scientific). The radioactively labelled probes were ethanol 
precipitated, and resuspended in 20 µl of RNase-free water. 
2.4 DNA methods 
 DNA purification and restriction digest 2.4.1
Genomic DNA used as a template for PCR was obtained as a by-product of the RNA 
isolation procedure (see Section 2.5.1). Following the addition of ethanol to precipitate the 
nucleic acid, the chromosomal DNA, which formed a stringy mass, was removed using the 
end of a sterile tip, washed with 70% (v/v) ethanol, pelleted by brief centrifugation (16,000 
x g for 30 s), and resuspended in TE buffer (pH 8.0) (Sigma). Restriction enzymes, used on 
PCR products, were obtained from New England BioLabs. DNA restrictions were carried out 
as per the supplier’s protocol. 
 DNA quantification 2.4.2
DNA samples with a relatively high concentration (> 5 µg/ml) were quantitated by 
spectrophotometry by measuring the absorbance at 260 nm with a Geneflow Perl 
nanophotometer. At this wavelength, an absorbance of 1 corresponds to approximately 50 
µg/ml of double-stranded DNA. For a low DNA concentration (< 5 µg/ml), the amount was 
estimated by running a sample on an agarose gel and comparing the intensity of the 
ethidium-bromide stained bands with those of marker bands of similar size and known 
concentration. 
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 DNA gel extraction 2.4.3
Following electrophoresis (see Section 2.2.1) DNA fragments were extracted from slabs 
excised from agarose gels using the QIAquick® Gel Extraction Kit, as per the manufacturer’s 
instructions (Qiagen). 
 Polymerase chain reaction (PCR) 2.4.4
PCRs were carried out as described in Sambrook et al., (1989). In general, annealing 
temperatures 5°C below the estimated Tm of the primers were used. An extension time of 1 
min was allowed for every 1 kb to be amplified. Cycles were repeated 35 times for all 
reactions unless otherwise stated. When a downstream reaction was to follow PCR, 
products were purified using the PCR purification kit (Quiagen). All primers used are 
presented in Table 2.2. 
Table 2.2 - Oligonucleotides used in this study. 
Name Sequence (5’ to 3’) 
Used for RLM-RT-PCR 
16S GATCCAACCGCAGGTTCC 
ftsT GGCTTCTCAACAGGTGGTGT 
pgpA TGCCACGGATTACTCATCTTC 
rhlB TGGGCGTACAGTTATGAAACC 
RLM1 CGAAGACAACAAAGAAGTTCAACTC 
RLM2 CATGAGGATTACCCATGTCG 
ymfK GGCCTGTACCCATGATATGAC 
Used for PCR and in vitro transcription 
5SF ATCCTAATACGACTCACTATAGGGTGGCGGATTGAGAGAAGATT 
5SR ATGCCTGGCAGTTCCCTACT 
9S F ATCCTAATACGACTCACTATAGGGAAGCTGTTTTGGCGGATGAG 
9S R ACGAAAGGCCCAGTCTTT 
argXF CGCGTAATACGACTCACTATAGGGAGGGGTGGGAAGTCCGTATTA 
argXR AGGGTGACGAAATGCACAGAA 
cspA F ATCCTAATACGACTCACTATAGGGTTTGACGTACAGACC 
cspA R2 AAAATCCCCGCCAAATGGCAGGG 
dnaKF ATCCTAATACGACTCACTATAGGGAAGACAAAGCCCTATCGAA 
dnaKR CTTTGTCACCCTGGTTACGG 
fumAF ATCCTAATACGACTCACTATAGGGCCGGACGGATGGATTCTTAT 
fumAR AAAAAAACCGCCCCGAAG 
glyWF TGCGTAATACGACTCACTATAGGGACTCATCGCGCCAGGTAAGTA 
glyWR AGGTGGTTTCACGACACTGCT 
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Table 2.2 (continued) 
manXF ATCCTAATACGACTCACTATAGGGCCTCTGTTAACGTCGGTGGT 
manXR ACCAGGGTACACGCGATTAG 
pheUF ATATTAATACGACTCACTATAGGGCGAGATGTGCAGATTACGGTTT 
pheUR GCACGACATTTCACGTCAGTT 
RNAI F ATCCTAATACGACTCACTATAGGGACAGTATTTG 
RNAI R AACAAAAAAACCACCGCTACC 
Used to generate 32P labelled oligoprobes 
ecr0174(u+) CCACGGCATATCTGACCTTATAAAGCCAAC 
ecr3777(d+) ACCTTTTCGGCTGTCTCTTCTCTCGTACTG 
ecr2775(u+) CTCAAGGGGAGAAAACTTAGGGCCTCTATG 
ecr4051(u+) CTGTATGTAGGGTACAGCACGATGAATCTG 
ecr1743(d+) GTATTACCGTAGTAATGCAAGCGCGTCTCAG 
AgrB ACTTTCCAGCCCTGAGTTGGTGGCTCTG 
Table 2.2 - Oligonucleotides used in this study. This table presents the name, orientation 
and 5’ to 3’ sequence of all primers and oligonucleotides used in this study and groups 
them based on what they were used for. 
 Cloning and sequencing of fragments produced by PCR 2.4.5
PCR products purified as described above (Section 2.4.4) were ligated into the pGEM-T® 
Easy vector as per the vendor’s instructions (Promega) and then the ligation mix was 
introduced by transformation into JM109 cells purchased in a competent state (Promega). 
The transformation mixture was spread on the surface of selective Luria Bertani agar 
(Sigma) that contained 50 µg/ml carbenicillin. Following transformations, colonies were 
picked and grown overnight in 10 ml Luria Bertani media containing 50 µg/ml carbenicillin. 
Plasmid DNA was extracted from these overnight cultures using the Wizard® Mini-prep 
DNA Purification system as per manufacturer’s instructions (Promega). Inserts of purified 
plasmids were sequenced by GATC-biotech (Germany) using universal primers SP6 and T7.  
2.5 RNA methods  
 Total RNA extraction  2.5.1
RNA was isolated from various E. coli strains (Section 2.1) following a protocol outlined 
previously (Kime et al., 2008a). Briefly, E. coli culture pellets corresponding to 5-8 OD600 
units were resuspended in 1 ml resuspension buffer; 10 mM Tris-HCl (pH 8.0), 1 mM EDTA. 
Cells were then lysed by adding 1 ml lysis buffer; 20 mM Tris-HCl (pH 8.0), 40 mM EDTA, 
300 mM NaCl, and 0.5% (w/v) SDS, which was preheated to 100°C. This mix was then 
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incubated in a boiling water bath for 30 s or until it turned translucent in appearance. After 
cooling in ice, an equal volume of acid phenol saturated with 100 mM citrate buffer (pH 
4.3) was added. This mix was briefly centrifuged (14,000 x g for 3 min) and the aqueous 
phase was retained. Total nucleic acid in the aqueous phase was precipitated by adding 2.5 
volumes of absolute ethanol. Precipitation was achieved by centrifugation at 7,000 x g for 
15 min at 4 °C. The pellet was thoroughly resuspended in 200 µl molecular biology-grade TE 
buffer (pH 8.0) (Sigma) containing 150 mM NaCl and re-precipitated by adding 500 µl 
absolute ethanol. Stringy chromosomal DNA was removed using a sterile tip and the 
remaining nucleic acid, largely RNA, pelleted by centrifugation at 14,000 x g for 20 min at 4 
°C. The RNA pellet was then resuspended in 400 µl resuspension buffer containing 150 mM 
NaCl and extracted further with an equal volume of acidic phenol (pH 4.3), an equal volume 
of acidic phenol: chloroform: isoamyl alcohol (25:24:1), and chloroform: isoamyl alcohol 
(49:1). RNA was reprecipitated by adding 2.5 volumes of absolute ethanol, pelleted by 
centrifugation at 14,000 g for 15 min at 4°C and washed twice in 70% (v/v) ethanol; a 5 min 
centrifugation at 14,000 x g at 4 °C was performed after each wash. The resulting pellet 
was air-dried and resuspended in 100 µl molecular biology-grade water (Sigma). 
In order to achieve DNA-free RNA, the harvested RNA was treated with RNase-free DNase I 
(Promega). 1 U DNase I was used to treat 100 µg of nucleic acid in 400 µl of 40 mM Tris-HCl 
(pH 8.0), 10 mM MgSO4, and 1 mM CaCl2 for 1 h at 37 °C. RNA was then extracted with an 
equal volume of acidic phenol: chloroform: isoamyl alcohol (25:24:1), NaCl was added to a 
final concentration of 150 mM, and the RNA precipitated by adding 2.5 volumes of absolute 
ethanol. The RNA was harvested by centrifugation at 14,000 x g for 15 min at 4 °C. Pellets 
were washed twice as above and resuspended in either water or TE buffer (pH 8.0) of 
molecular biology grade (Sigma).  
 Total RNA enrichment 2.5.2
Total RNA was enriched for mRNA by removing 16S and 23S rRNA using the 
MICROBExpress rRNA removal kit as per the manufacturer’s instructions (Ambion). The 
average yield from 10 µg of total RNA was 3 to 4 µg of enriched RNA. Successful removal of 
excess 16S and 23S rRNA was assessed by analysing 1 µg samples by gel electrophoresis 
using 2% (w/v) agarose gels. RNA samples were loaded using 2 x RNA loading dye; 95% 
(v/v) formamide, 0.025% (w/v) bromophenol blue, 0.025% (w/v), xylene cyanole and 
0.025% (w/v) SDS (Ambion). 
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 Northern blotting 2.5.3
RNA for northern blotting was isolated as described previously (see Section 2.5.1), with the 
exception that the mRNA was not enriched, from a second batch of cultures. E. coli K-12 
MG1655 (seq) was grown in Luria-Bertani (Amresco) as well as M9 minimal media (Sigma) 
supplemented with glucose (0.4%,w/v) at 37°C with shaking (100 rpm) until an OD600 of 
~0.5 at which point RNA was isolated as described previously (Kime et al., 2008b). For each 
sample, an aliquot of 5 µg was mixed with an equal volume of 2 x RNA-loading dye (New 
England BioLabs), denatured by incubation at 90°C for 90 sec, chilled on ice, and analysed 
along with other samples by denaturing electrophoreses using a 6% sequencing-type gel 
(acrylamide: bis-acrylamide [29:1], 1 x TBE, 7 M urea). Fractionated RNA was electro-
transferred to a Hybond-N+ membrane (Amersham) using 20 x saline-sodium citrate (SSC) 
buffer at 11 V for 1 h, and subsequently fixed to the membrane by UV-crosslinking. The 
membrane was pre-hybridized with 3 ml of ULTRAhyb-Oligo Hybridization Buffer (Ambion) 
at 42oC for 30 min. 
Radiolabelled probe, which had been denatured by incubation at 90°C for 90 sec and 
chilled on ice, was added to the hybridization tube. Hybridization was carried at 42°C 
overnight. The membrane was washed twice with 20 ml of preheated washing buffer (5 x 
SSC containing 0.5% [w/v] SDS) at 49°C for 30 min and exposed to Imaging Screen-K (Bio-
Rad). The image was captured by Molecular Imager FX (Bio-Rad), and further processed 
using Quantity One (Bio-Rad) and GeneSys (Syngene) software. 
 Global RNA sequencing 2.5.4
Global Transcriptome sequencing was performed by Dr. Lira Mamanova (Wellcome Trust, 
Sanger Institute, Cambridge, UK) using a published methodology (Mamanova et al., 2010). 
Sequencing was performed using an Illumina Genome Analyzer (HiSeq 2000). RNA 
sequences were processed in-house using Galaxy (Goecks et al., 2010) and mapped onto 
the E. coli reference genome (NCBI accession number U00096.2) using Bowtie 2.0 
(Langmead and Salzberg, 2012) with custom parameters: -l 28 for read, -l 20 for read2, and 
-y -a --best --strata. For every position in the genome, the number of times it was read 
irrespective of its position in the individual RNA fragments was determined using a 
combination of BEDtools (Quinlan and Hall, 2010) and bash scripts (this script was written 
and run by Vijaya Mahalingam Shanmugiah). These counts were then recorded in the 
format of a bedGraph (part of the UCSC format options) and visualized using the UCSC 
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genome browser (Schneider et al., 2006; Chan et al., 2012). The above sequencing data was 
submitted to the GEO repository (Edgar et al., 2002) and is stored under accession number 
GSE46232. 
 Differential RNA sequencing 2.5.5
Prior to differential RNA-seq, samples were enriched for mRNA using MICROBExpress-
Bacteria beads, as described previously (see Section 2.5.2). Differential RNA-seq was 
performed by Vertis Biotechnologie AG (Germany) as part of a service that included the 
construction of cDNA libraries before and after treatment with TAP, sequencing of libraries 
using an Illumina HiSeq platform (single end, 50-bp read length), and the alignment of 
sequences to the E. coli K12 sub-strain MG1655 genome (NCBI, accession number 
U00096.2). The 5’-sequencing adaptor was ligated to transcripts prior to fragmentation, 
thereby allowing the 5’ ends of both long and short transcripts to be detected. RNA was 
fragmented using a Bioruptor® Next Gen UCD-300 ™ sonication system (Diagenode), then 
tailed at the 3’ end using poly(A) polymerase (New England BioLabs), copied into cDNA 
using M-MLV reverse transcriptase (RNase H minus, AffinityScript, Agilent) and an oligo-dT 
primer, amplified by PCR and fractionated using gel electrophoresis. Fragments of 250 - 500 
bp were selected for Illumina sequencing. Reads were trimmed off the 5’ adapter and 
poly(A) sequences and mapped using the CLC Genomics Workbench and standard settings. 
For each library, the number of times each genome position was the first nucleotide in 
sequence reads (i.e. associated with a 5’ end in vivo) was counted using a combination of 
BEDtools (Quinlan and Hall, 2010) and bash scripts (this script was written and run by 
Vijaya Mahalingam Shanmugiah). The reads corresponding to minus and plus TAP 
treatment were then compared using M-A scatterplots. The counts were also recorded in 
bedGraph format (part of the UCSC format options) to allow visualisation using the UCSC 
genome browser (Schneider et al., 2006; Chan et al., 2012). This dRNA-seq data was also 
submitted to the GEO repository (Edgar et al., 2002) and stored under accession number 
GSE46232. 
 RNA synthesis by in vitro transcription. 2.5.6
Transcription reactions were carried out as 40 µl reactions containing 80 U RNaseOUT™ 
(Invitrogen), 5 mM DTT, 1 U yeast inorganic pyrophosphatase (Sigma), 100-150 nM 
template, 2.5 mM rNTP mix (GE Healthcare) and 100 U T7 RNA polymerase (Invitrogen) in 1 
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x T7 RNA polymerase buffer: 0.04 M Tris-HCl (pH 8.0), 8 mM MgCl2, 2 mM spermidine-
(HCl)3, 25 mM NaCl. 
Reactions were incubated at 37 °C for 3 h. Templates were generated via PCR. Following 
incubation, 2 U of DNase I (Promega) and 40 U RNAseOUT™ (Invitrogen) were added to the 
reaction which was incubated at 37 °C for a further 1 h. 
Following DNase I treatment, reactions were extracted with an equal volume of phenol: 
chloroform and then phenol: chloroform: isoamyl alcohol (25:25:1). The RNA was 
precipitated by adding 0.1 volumes of 3 M sodium acetate (pH 5.5) and 2.5 volumes of 
100% (v/v) ethanol. The RNA was then harvested by centrifugation at 16,000 x g for 10 min 
at 4°C. The pellets were washed twice with 500 µl ice-cold 70% (v/v) ethanol. Pellets were 
then air dried and re-suspended in 40 µl of molecular biology-grade water (Sigma). Samples 
were mixed with an equal amount of 2 x RNA loading dye (Ambion) and separated on a 
denaturing polyacrylamide gel (Section 2.2.2). RNA was visualized using a GeneGenius UV 
transilluminator (Syngene) set at an excitation wavelength of 302 nm after incubating the 
gels in 1 x TBE buffer containing 1 μg/ml ethidium bromide for 5 min. 
 Discontinuous cleavage assays 2.5.7
The discontinuous cleavage assay used here was adapted from a previously published 
method (Redko et al., 2003). The oligoribonucleotide substrates used during this thesis 
were 3’ fluorescein-labelled versions of BR13 (5’-GGGACAGUAUUUG-3’; (Mcdowall et al., 
1995)). Two versions were used; one with a 5’-monophosphate (PBR13-Fl) and the other 
with a 5’-hydroxyl group (HOBR13-Fl). These substrates were synthesized and purified by 
Dharmacon (USA). Reactions were carried out in 1 x reaction buffer (RB): 25 mM bis-Tris-
propane (pH 8. 3), 100 mM NaCl, 15 mM MgCl2, 0.1% (v/v) Triton X-100, and 1 mM DTT. 
Unless otherwise indicated, reactions with oligonucleotides contained substrate and 
enzyme at concentrations of 250 and 5 nM, respectively, as well as 0.32 U/μL of 
RNaseOUT™ (Invitrogen). Before starting the reaction, all components were pre-warmed at 
37°C for 15 min. Samples removed for analysis were quenched immediately by mixing with 
an equal volume of 2 x RNA loading dye: 95% (v/v) formamide, 0.025% (w/v) bromophenol 
blue, 0.025% (w/v), xylene cyanole, and 0.025% (w/v) SDS (Ambion). All reactions were 
incubated at 37°C. Samples were separated in denaturing polyacrylamide gels (Section 
2.2.2). Reaction products were detected using a Fuji FLA 5000 scanner (Fuji) set to 
fluorescein detection (excitation wavelength 473 nm, filter 523 ±35 nm). Substrate and 
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product were quantified using the AIDA Image Analyzer software package (Raytest 
Isotopenmessgeräte GmbH). Initial rates of reaction were calculated by establishing the 
slope representing the percentage of product produced over time during the initial, linear 
phase of the reaction. Rates were then calculated taking into account concentrations of 
enzyme and substrate in the reaction mix. 
Total RNA cleavage assays were performed in the same way as oligoribonucleotide 
cleavage assays; only substrate and enzyme concentrations were varied to 10 µg and 250 
nM, respectively. Furthermore when samples were taken, the reaction was quenched and 
the RNA extracted by increasing the volume to 400 µl with TE buffer (pH 8.0) (Sigma), 
adjusting the salt concentration to 150 mM NaCl and immediately extracting the RNA as 
described in Section 2.5.1. 
 Enzymatic modifications of RNA 2.5.8
RNA was subjected to a repertoire of enzyme treatments in order to modify the 5’ and 3’ 
end. TerminatorTM 5’ phosphate-dependent exonuclease (TEX) treatments were typically 
performed in 40 µl reactions containing 40 U RNaseOUTTM (Invitrogen) and 1 U TEX 
(Epicentre Biotechnologies) per 1 µg of RNA in 1 x TEX buffer A (Epicentre Biotechnologies). 
Reactions were incubated at 30°C for 1.5 h. Tobacco acid pyrophosphatase (TAP) 
treatments were performed in 40 µl reactions containing 3 U of TAP (Epicentre 
Biotechnologies) per 1 µg RNA in 1 x TAP buffer: 0.5 M sodium acetate (pH 6.0), 10 mM 
EDTA, 1% β-mercaptoethanol, and 0.1% Triton® X-100. Reactions were incubated at 37°C 
for 2.5 h. T4 polynucleotide kinase (PNK) treatments were performed in 30 µl reactions 
containing 40 U RNaseOUTTM (Invitrogen), 100 mM ATP and 13 U of PNK (New England 
BioLabs) per 1 µg RNA in 1 x PNK buffer: 70 mM Tris-HCl (pH 7.6), 10 mM MgCl2, and 5 mM 
dithiothreitol. Reactions were incubated at 37°C for 1.5 h. Poly(A) polymerase treatments 
were performed in 30 µl reactions containing 40 U RNaseOUTTM (Invitrogen), 1 mM ATP 
and 4 U of Poly(A) polymerase (New England BioLabs) per 1 µg of RNA in 1 x Poly(A) 
polymerase buffer: 50 mM Tris-HCl (pH 7.9), 250mM NaCl, and 10mM MgCl2. Reactions 
were incubated at 37 °C for 10 min.  
Following all treatments, volumes were adjusted to 400 µl, NaCl added to 150 mM NaCl 
and phenol: chlorophorm extracted as in Section 2.5.1. Samples were ethanol precipitated 
and resuspended in molecular biology grade water (Sigma). 
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 RNA-ligase mediated, reverse-transcription PCR assay 2.5.9
This method was performed as described previously (Kime et al., 2008a). Briefly, this 
method consists of three reactions: an RNA ligation, followed by a reverse transcription, 
and finally PCR. 
For the ligation reaction, 20 pmol of an RNA adapter was mixed with 1.2 µg of total RNA, 5 
U of T4 RNA ligase (New England BioLabs), 20 U of RNaseOUT™, 1 mM ATP in 10 µl RNA 
ligase buffer: 50 mM Tris-HCl (pH 7.8), 10 mM MgCl2, 10 mM DTT, and 1 mM ATP. The 
reaction was then incubated at 37°C for 1 h. The adapter used was a 54-mer, with 
sequence:           
5’-ACAUGAGGAUUACCCAUGUCGAAGACAACAAAGAAGUUCAACUCUUUAUGUAUU-3’ which 
was synthesized by Dharmacon (USA). For the reverse transcription reaction, 50 ng of 
random hexamers (Amersham Biosciences) were annealed to 600 ng of ligated RNA in a 
volume of 20 µl molecular biology grade water (Sigma). This mix was heated at 65°C for 5 
min and snap chilled on ice and added to a solution containing 250 mM Tris-HCl (pH 8.3), 
375 mM KCl, 15 mM MgCl2, 50 mM DTT, 4 µl of a 10 mM stock of dNTPs, 80 U of 
RNaseOUT™ (Invitrogen) and molecular biology-grade water (Sigma) to a final volume of 40 
µl. Following this, two 19 µl aliquots were processed further. 200 U (1 µl) of MMLV reverse 
transcriptase RNase H minus (Promega) was added to one, and 1 µl water to the other. 
These mixes when then incubated at 25°C for 15 min, 42°C for 1 h, and finally 70°C for 15 
min. At the end of the reaction, 80 µl of 10 ng/ml yeast tRNA (Ambion) was added. For the 
PCR reaction, the same conditions as in Section 2.4.4 were followed using RLM-2 (Table 
2.2), which is complementary to the 5’ adaptor and a gene-specific primer (Table 2.2). 
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Chapter 3 
3 Enzyme characterization and workflow set up 
3.1 Introduction 
RNA sequencing technologies have improved to a point where it is now possible to 
sequence entire bacterial genomes and transcriptomes in a single sequencing run (Cho et 
al., 2009; Sharma et al., 2010; Lin et al., 2013b; Wang et al., 2013; Al Rashdi et al., 2014; 
Benahmed et al., 2014; Hasman et al., 2014). Recently, by removing the products of 
processing and the intermediates of mRNA degradation (the ‘secondary’ transcriptome) 
using Terminator™ Exonuclease (TEX), a 5’-3’ enzyme that is specific for 5’-
monophosphorylated ends, it was possible to generate more than enough reads using 454 
sequencing (2 to 4.5 million) to map transcriptional start sites (TSSs) on a genome-wide 
scale (see Section 1.4). This involved a second enzymatic treatment with tobacco acid 
pyrophosphatase (TAP) to produce a 5’-monophosphate on the nascent ends to permit 
their cloning and subsequent sequencing. This differential RNA (dRNA)-seq approach, 
described initially for Helicobacter pylori (Sharma et al., 2010), is being used extensively to 
map TSSs in other prokaryotes including archaea (Butcher and Stintzi, 2013; Cortes et al., 
2013; Lin et al., 2013b; Pfeifer-Sancar et al., 2013; Rumbo-Feal et al., 2013). 
Since the initial description of dRNA-sequencing, Illumina sequencing has been replacing 
454 sequencing in the mapping of the transcriptional landscapes of bacteria. Illumina 
technology is less expensive and can generate 10 fold more reads than its 454 equivalent. 
Moreover, although Illumina reads are shorter, they are sufficiently long (30 to 50 bp) to 
allow unambiguous assignment to positions within bacterial chromosomes. This suggested 
that differential RNA sequencing could be performed without erasing the secondary 
transcriptome, provided that TAP could be shown to remove pyrophosphates from 5’ 
nascent ends efficiently. If it could, the subtraction of 5’ end fragments before treatment 
from those detected after treatment with TAP would identify those associated with 
nascent ends. There was also a concern that TEX might be less efficient at degrading RNA 
from S. coelicolor, another bacterial species of interest to the laboratory (Uguru et al., 
2005; Hong et al., 2007; Van Wezel and Mcdowall, 2011), as it has a high GC-content, which 
in turn can introduce more stable secondary structures into RNA. This chapter describes 
the development of the front end of a pipeline that allowed the nature of 5’ ends to be 
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differentiated using TAP rather than TEX. In addition, it describes biochemical confirmation 
that the T170V mutant of RNase E reduces the efficiency of cleavages dependent on, but 
not those independent of the presence of a 5’-monophosphate, and the preparation of 
samples of total RNA digested with T170V for analysis by RNA–sequencing. The work 
relates to the broad objective of developing an approach that provides, for the first time, a 
transcriptome-wide view of steps in RNA processing and decay, with a focus on the role of 
direct-entry cleavage by RNase E. As described (Chapter 1), the laboratory has produced 
biochemical evidence that suggests many of the cleavages produced by RNase E might be 
independent of interaction with a 5’-monophosphorylated end. Moreover, the T170V 
mutant has been used in prior studies of RNase E cleavage (Kime et al., 2010; Kime et al., 
2014). The threonine substitution for valine removes one of three hydrogen bond donors 
that can engage a 5’-monophosphorylated end (see Figure 1.4). A major role for direct 
entry would explain, at least in part, why the normal rapid degradation of only a proportion 
of the mRNAs in E. coli is highly dependent on 5’ pyrophosphate removal by RppH (Deana 
et al., 2008; Kime et al., 2010). 
3.2  Results 
  Removal of 23S and 16S rRNA from total RNA 3.2.1
To reduce the number of reads that would correspond to rRNA, a MICROBExpress kit 
(Ambion) was used to deplete rRNA from total RNA isolated from E. coli after it was treated 
with DNase I (Figure 3.1). MICROBExpress (Ambion) is a commercially available kit which 
removes 16S and 23S rRNA from a sample by using oligonucleotides that are 
complementary to these rRNAs and are immobilised on magnetic beads. RNA from an rppH 
deletion strain (JW2798Δkan) as well as a congenic wild-type strain (BW25113) were 
included to provide samples for the analysis of direct-entry cleavage (see below). The 
analyses confirmed that the DNase I treatment removed all visible signs of contaminating 
chromosomal DNA and the MICROBExpress kit removed the vast majority of 23S and 16S 
rRNA (>95%, as specified by the manufacturer) without causing any degradation of the 
samples. Interestingly, a band of small RNA and a much larger RNA species of unknown 
identity (marked sRNA and by a double asterisk respectively) were detected in the ΔrppH 
strain. The degradation or processing of these species appears to be dependent on 5’ 
pyrophosphate removal. 
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Figure 3.1 - Removal of large ribosomal RNA species from E. coli total RNA samples. Total 
RNA isolated from E. coli rppH (lane 1) and its congenic wild-type, BW25113, (lane 2) was 
treated with DNase I in order to remove chromosomal DNA (labelled *) and then enriched 
for mRNA with the MICROBExpress kit (Ambion). The marker lane (labelled M) contains a 
GeneRuler 100 bp Plus DNA Ladder (Fermentas). Numbers at the left hand side of the panel 
indicate the sizes (bp) of selected markers, whereas the labelling at the right hand side 
indicates the position of 23S, 16S, 5S rRNA, tRNA, and smaller RNA species (sRNA). A large 
species that is more abundant in the ΔrppH strain is indicated by double asterisks (labelled 
**). The amount loaded was 1 µg of total RNA or the equivalent amount of enriched RNA. 
RNA was extracted from exponential cell cultures (0.6 OD600 units) grown in LB media. 
Electrophoresis was performed using a 2% (w/v) agarose gel. 
 Characterisation of TAP 3.2.2
Having found a straightforward method for removing the bulk of the large rRNA in E. coli, 
the next step was to confirm that TAP removes 5’ pyrophosphates efficiently. This required 
the synthesis of 5’-triphosphorylated substrate. The template for T7 polymerase mediated 
in vitro transcription of cspA mRNA, which was the subject of previous studies (Hankins et 
al., 2007; Hankins et al., 2010; Kime et al., 2010), was generated by PCR, as described 
previously (Kime et al., 2010). The amplicon was of expected size (444 bp) and could be 
transcribed to produce a single RNA species of the expected size (423 nt) (Figure 3.2). 
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Figure 3.2 - Preparation of 5’ triphosphorylated cspA mRNA. A template for production of 
cspA mRNA in vitro was generated by PCR using primers cspA F and cspA R2 (Table 2.2) 
(panel A) and then transcribed in vitro using T7 RNA polymerase (for details, see Section 
2.5.6) (panel B). Amplicon and transcript sizes are indicated on the right. The source of 
markers in both panels was the GeneRuler 100 bp Plus DNA Ladder (Fermentas) which in 
panel B is denatured and was used to give a rough estimate of size. The PCR amplicon (~1.3 
µg) was analysed by agarose gel electrophoresis (panel A), whereas, the in vitro-transcribed 
RNA was analysed under denaturing conditions using a 7 M urea, 7% (w/v) polyacrylamide 
(19:1) gel (panel B) and both were stained using ethidium bromide.  
RNA generated by in vitro transcription is 5’-triphosphorylated (Golomb and Chamberlin, 
1974). Incubation with TAP and TEX individually did not produce a detectable change in the 
migration of the cspA transcript (Figure 3.3). This was the expected result as pyrophosphate 
removal does not change the length of a transcript significantly and TEX is reported to be 
specific for 5’-monophosphorylated substrates. Incubation with TEX following treatment 
with TAP resulted in the efficient degradation of the cspA transcript. Indeed, residual 
substrate was not detected. This indicated that the TAP treatment was efficient. Moreover, 
the TAP treatment on its own did not result in any decrease in the intensity of the major 
cspA species nor the appearance of additional bands. This result, which was obtained 
independently by other members of the laboratory, indicated that the preparation of TAP 
was free of RNase contamination. It was found, in our laboratory, that some commercial 
preparations of enzymes used to treat the 5’ end of RNA can be contaminated with RNases. 
Calf-intestinal (alkaline) phosphatase (CIP) was trialled in combination with T4 
polynucleotide kinase (PNK) to monophosphorylate the 5’ ends of nascent transcripts. 
However, a source of CIP that was not contaminated with RNase activity could not be 
found (data not shown). 
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Figure 3.3 – Characterisation of TAP and TEX treatments. cspA mRNA was incubated in the 
absence of enzyme as a negative control (labelled C) or with TAP, TEX, or TAP followed by 
TEX (labelled at top of panel). The reactions were performed as outlined in Section 2.5.8. 
Aliquots of RNA (~500 ng) of each treatment were analysed by denaturing, polyacrylamide 
gel electrophoresis. The 10% (w/v) polyacrylamide (19:1) gel and was stained using 
ethidium bromide. 
In parallel, the specificity of TEX for 5’-monophosphorylated ends was checked by co-
incubating 5’-triphosphorylated cspA with an RNA oligoribonucleotide, R1, that had been 
monophosphorylated at its 5’ end using T4 polynucleotide kinase (Figure 3.4). Only the 
oligonucleotide was degraded by TEX. This confirmed that the efficient degradation of cspA 
mRNA following TAP treatment was due to the generation of 5’-monophosphorylated ends. 
5’-hydroxylated R1 was not degraded by TEX (Lin, unpub. result). 
 
Figure 3.4 – Assay of the specificity of TEX towards 5’ phosphorylated ends. 3 µg of an 
equimass mix of a 5’-monophosphorylated RNA oligonucleotide (labelled R1) (5’-
CCUUUUCAAGACAUGCAACAAUGCACACAG-3’) and 5’-triphosphorylated cspA mRNA 
(labelled cspA) was incubated with 3 U TEX. Samples of the reaction were taken after 0, 30 
and 70 min and electrophoresed, along with a control which was incubated without TEX for 
70 min (labelled C), on a 13% denaturing polyacrylamide gel with staining using ethidium 
bromide. 
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 Characterisation of the RNase E T170V substitution 3.2.3
3.2.3.1 Determination of the enzyme stock concentration 
Prior to conducting enzymatic comparisons, the concentrations of laboratory stocks of 
preparations of NTH-RNase E and the T170V mutant were confirmed by comparing aliquots 
against a dilution series of BSA standards using SDS-PAGE (Figure 3.5). Both NTH-RNase E 
and T170V migrated with an apparent mass of ~ 65 kDa, as previously described (Callaghan 
et al., 2003; Callaghan et al., 2005; Chandran and Luisi, 2006). Previously, each of the two 
stocks had been adjusted to 2 µM (tetramer concentration) on the basis of 
spectrophotometric analysis (absorbance at 280 nm); this corresponds to 500 ng/ µl. In 
agreement, the intensity of the bands corresponding to 1 µl aliquots of RNase E were 
similar to the band of BSA corresponding to 500 ng. The results of this analysis were also 
consistent with the preparations being described as >95% pure. The preparations had been 
purified as described previously (Kime et al., 2008a). 
 
Figure 3.5 - Determination of NTH-RNase E and T170V mutant stock concentration. A 
serial dilution of BSA was prepared and aliquots containing amounts ranging from 20 to 
2000 ng were compared against 1 and 5 µl volumes of NTH-RNase E and T170V. The 
intensity produced by loading 1 µl aliquots of preparations of NTH-RNase E and the T170V 
mutant correlated to that of the 2000 ng BSA standard marker. Markers (labelled M) are 
the Benchmark pre-stained protein ladder (Invitrogen) and the size, in kDa, of selected 
markers are labelled on the left. The gel was 18% (w/v) acrylamide (19:1).  
3.2.3.2 Assessment of enzyme stock activity  
Next the activity of the stocks described above was confirmed using derivatives of the 
oligonucleotide substrate BR13 that were labelled with fluorescein at the 3’ end and had 
either a monophosphate or hydroxyl group at the 5’ end. These substrates have been used 
previously to characterise mutants in the 5’ sensor domain of RNase E and RNase G 
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(Jourdan and Mcdowall, 2008; Kime et al., 2008a). As reported previously, the 5’-
monophosphorylated substrate was cleaved less efficiently by the T170V mutant than wild-
type NTH-RNase E (Figure 3.6). The 5’-hydroxylated substrate was cleavage inefficiently by 
both enzymes. The differences in the initial rates were also in accordance with what had 
been reported previously (Jourdan and Mcdowall, 2008). T170V cleaved 5’-
monophosphorylated BR13 11-fold slower than NTH-RNase E (1 vs 11.7 nM/min, 
respectively). The initial rates for cleavage of 5’-hydroxylated substrate by T170V and NTH-
RNase E were similar to each other but slower than 5’ –monophosphorylated BR13 (0.4 and 
0.27 nM/min respectively). 
 
 
Figure 3.6 - Characterisation of the RNase E T170V mutant. A discontinuous cleavage assay 
containing derivatives of BR13 and either T170V or wild-type RNase E was electrophoresed 
on a 7M urea, 13% (w/v) polyacrylamide (19:1) gel. The concentrations of substrate and 
enzyme at the start of the reaction were 250 nM and 5 nm, respectively. For PBR13, time 
points were taken at 0, 2, 5, 10, 50, 120 and 180 min following addition of substrate to the 
reaction; time points for HOBR13 were taken at 0, 10, 50, 120, 180 and 330 min. All 
reactants were pre-warmed at 37 :C for 30 min (Kime et al., 2010) prior to starting the 
reactions. Substrate bands are labelled S whilst products are labelled P, indicated on the 
right. 
The activity of these enzyme stocks were also confirmed using cspA in vitro transcribed 
mRNA (Kime et al., 2010). Unlike the BR13 oligonucleotide substrate, cspA mRNA is cleaved 
efficiently in the absence of a 5’-monophosphate (Kime et al., 2010). To provide a control, 
RNAI, the antisense RNA regulator of ColE1 replication was included. It is well established 
that cleavage of this RNA requires interaction with a 5’-monophosphate (Jiang et al., 2000; 
Kime et al., 2010). As described above for cspA mRNA (Section 3.2.2), RNAI RNA was 
generated by in vitro transcription from templates produced by PCR. Both the amplicon 
and its transcriptional product migrated as expected for their predicted sizes, which were 
132 bp and 111 nt (Figure 3.7). Following in vitro transcription, cspA and RNAI transcripts 
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where incubated with NTH-RNase E and T170V (Figure 3.8). It was shown that, as reported 
recently (Kime et al., 2010), 5’-triphosphorylated cspA mRNA was cleaved efficiently by 
both NTH-RNase E and T170V. The site of cleavage is located close to the 3’ end (Hankins et 
al., 2007; Kime et al., 2010) producing a detectable upstream product (labelled p) that 
migrates slightly faster than the full-length substrate. As expected, RNAI was not cleaved by 
either NTH-RNase E or T170V. 
A 
 
B 
 
Figure 3.7 - Preparation of 5’-triphosphorylated RNAI RNA. The template for the in vitro 
synthesis of RNAI RNA was generated by PCR using primers RNAI F and RNAI R (Table 2.2) 
(panel A). The template was then transcribed in vitro using T7 RNA polymerase, (see 
Section 2.5.6) (panel B). Amplicon and transcript sizes are indicated on the right. The 
marker (lane M) in panel A was the GeneRuler 100 bp Plus DNA Ladder (Fermentas) and for 
panel B the marker was the RiboRuler™ low range RNA ladder (Fermentas). The sizes of the 
markers are indicated on the right of each panel. The PCR amplicon (~1.3 µg) was analysed 
by agarose gel electrophoresis, whereas, the in vitro-transcribed RNA was analysed under 
denaturing conditions using a 7 M urea, 7% (w/v) polyacrylamide (19:1) gel and both were 
stained using ethidium bromide. 
A 
 
B 
 
Figure 3.8 – Cleavage of cspA and RNAI mRNA by the N-terminal half of RNase E.  The 
concentrations of substrate and enzyme at the start of the reaction were 0.64 µM of cspA 
mRNA (panel A) or RNAI (panel B) and 25 nM of wild-type NTH-RNase E or the T170V 
mutant, respectively (see Section 2.5.7). Samples were taken at 0, 5, 15, 30 and 60 min 
following addition of substrate to the reaction. A control of each mRNA which was 
incubated in the absence of enzyme for 60 min was also electrophoresed (lanes labelled C). 
The samples were analysed under denaturing conditions using a 7 M urea, 7% (w/v) 
polyacrylamide (19:1) gel and were stained using ethidium bromide. 
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 Determination of conditions for the incubation of total RNA with RNase E 3.2.4
and T170V 
Following empirical testing, conditions were obtained that resulted in detectable cleavage 
of total RNA samples (Figure 3.9). Incubation of NTH-RNase E (300 nM) with total RNA (10 
µg/180 µl reaction) from wild-type E. coli (BW25113) or the congenic rppH strain 
(JW2798Δkan) for 15 min was sufficient to detect significant amounts of cleavage as 
evidenced by the appearance of discrete product bands and a reduction in the intensity of 
the large rRNA species, in particular 16S rRNA. Total RNA from the rppH strain was 
included to evaluate the overall contribution of 5’ pyrophosphate removal on cleavage by 
RNase E. Interestingly, cleavage in terms of level and pattern was broadly similar, although 
not identical, to that of the equivalent RNA from the wild-type strain. This result suggested 
that the absence of 5’-monophosphorylated ends that would normally be generated by 
RppH does not have a major effect on RNase E cleavage of total RNA, at least in vitro. 
However, absence of rppH did not prevent enriched mRNA being susceptible to TEX (Figure 
3.10). One explanation for this observation, which is discussed in Chapter 1 is that the 
majority of the RNAs in total RNA do not correspond to nascent transcripts and are in fact 
degradation intermediates. Regardless of the composition of visible species in total RNA, it 
appears that direct entry may be a major pathway of RNase E cleavage. For both RNA 
samples, incubation with T170V and NTH-RNase E produced similar levels and patterns of 
cleavage (Figure 3.9). The actual sites of cleavage were then mapped using an RNA 
sequencing approach that is described in Chapter 1. 
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Figure 3.9 - Cleavage of total RNA by the N-terminal half of RNase E and the T170V 
mutant. Total RNA was isolated from a ΔrppH mutant of E. coli and BW25113, a congenic 
wild-type strain. The amount of total RNA in each 180 µl of reaction was 10 µg. The 
concentration of enzyme at the start of the reaction was 300 nM. Samples were removed 
prior to the addition of enzyme (corresponding to lane 0) and after 15 and 120 min of 
incubation. The reaction conditions were as described (Section 2.5.7). The samples were 
extracted with phenol chloroform and precipitated with ethanol and 1 µg of each sample 
was then resuspended in loading buffer and analysed by agarose gel electrophoresis. 
Markers, labelled on the left of the panel, and gel electrophoresis are as Figure 3.1. The gel 
was 2% agarose (w/v). Numbers at the top of the panel indicate the time (min) at which 
samples were removed from each reaction. 
 
Figure 3.10 - TEX treatment of E. coli total RNA samples. Enriched mRNA (labelled 
Enriched) samples from E. coli strains BW25113 and its congenic ΔrppH mutant were 
treated with TEX (labelled TEX). Reaction conditions were as outlined in Section 2.5.8. The 
amount of RNA loaded was 1 µg of total RNA or the same amount of TEX treated RNA. The 
gel was 1.5% (w/v) agarose and stained with ethidium bromide. 
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3.3 Discussion 
The work described in this chapter successfully: i) showed that the majority of 23S and 16S 
rRNA could be removed using the MICROBExpress system, with the aim of enabling better 
coverage of non-ribosomal species by RNA sequencing (Figure 3.1); ii) demonstrated that 
tobacco acid pyrophosphohydrolase (TAP) provides an effective means of discriminating 
the phosphorylation status at the 5’ ends of transcripts (Figure 3.3 and Figure 3.4); iii) 
confirmed that the T170V mutant of RNase E is deficient in 5’-end sensing (Figure 3.6 and 
Figure 3.8); and iv) established the conditions for the cleavage of total RNA by NTH-RNase E 
in vitro (Figure 3.9). These results largely represent the preparatory work for RNA-
sequencing analysis that ultimately proved to be successful (Chapter 4). 
A finding that was initially unexpected was generated when preparing total RNA. In RNA 
prepared from the ΔrppH mutant there are small RNAs that migrate faster than tRNA that 
appear to accumulate (Figure 3.1). This RNA species could be sRNAs that are stabilized as a 
result of not being ‘decapped’ by RppH or mRNA transcripts with structured 5’ UTRs, which 
can only be degraded via interaction with the 5’-monophosphate sensing pocket of RNase 
E. 
Results of assaying the cleavage of total RNA also indicated that the majority of the 
cleavages produced by NTH-RNase were also produced by T170V. There was no substantial 
difference in the rate or pattern of cleavage (Figure 3.9). This result is consistent with the 
notion that direct-entry cleavage might, contrary to what has been suggested recently 
(Garrey et al., 2009), not be the exception. Our laboratory has proposed that the tetrameric 
structure of RNase E allows it to bind to substrates with high affinity provided it can contact 
simultaneously a single-stranded segment(s) in addition to the one in which cleavage 
occurs. The apparent widespread nature of direct entry, as found here (Figure 3.9), is 
consistent with such a simple requirement. 
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Chapter 4 
4 Mapping of sites of RNase E cleavage within the transcriptional 
landscape of Escherichia coli as determined using a combination of 
global and differential RNA-seq 
4.1 Introduction 
Since its discovery in 1885 by Theodor Escherich, a German paediatrician, (Escherich, 1885) 
Escherichia coli has become an important model system for studying molecular and 
bacterial biology and establishing biotechnological platforms. E. coli is perhaps best known 
for being the organism that hosts the majority of recombinant DNA work. The first 
complete DNA sequence of an E. coli genome, laboratory strain K-12 derivative MG1655 
(seq), was published in 1997 (Blattner et al., 1997). It consists of 4.6 Mbp and is currently 
annotated as encoding 4,284 protein-coding genes (Keseler et al., 2013) organised as 2,642 
operons (Salgado et al., 2006), seven rRNA operons, and 86 transfer RNA genes (Keseler et 
al., 2013). The genome also contains a significant number of transposable genetic 
elements, repeat elements, cryptic prophages, and the evolutionary remnants of 
bacteriophages (Blattner et al., 1997). 
The availability of the DNA sequence of MG1655 (seq) (Blattner et al., 1997), and now 
many other strains, permits the study of E. coli on a genome-wide scale. For example, there 
have been hundreds of studies on the control of gene expression at the RNA level using 
microarrays (Schena et al., 1995; Bier and Kleinjung, 2001; Goldsmith and Dhanasekaran, 
2004) and more recently global RNA sequencing approaches (Butcher and Stintzi, 2013; 
Cortes et al., 2013; Lin et al., 2013b; Pfeifer-Sancar et al., 2013; Rumbo-Feal et al., 2013) 
alongside studies at the protein level using 2D-gel electrophoresis, a method which was 
used to assemble a 2D PAGE database (Appel et al., 1996) and has now shifted to the use of 
mass spectrometry approaches (Arifuzzaman et al., 2006; Cho et al., 2009). High-
throughput approaches are also being developed to map macromolecular interactions 
(protein-protein and protein-nucleic acid) and the flux through major metabolic pathways 
(Rajagopala et al., 2014). This system level understanding provides an envelope in which to 
model the underlying regulation. E. coli offers an attractive model for systems biology, not 
only because of the relative ease with which it can be grown, but because much more is 
probably known about the mechanisms that regulate gene expression in E. coli than any 
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other organism. However, as is true for all model organisms, knowledge of the mechanism 
involved in mediating and regulating RNA degradation lags behind that of transcription and 
translation. 
As outlined in Chapter 1, with the advent of microarrays it was possible to begin to identify 
transcripts whose degradation was dependent on particular mRNA decay factors (e.g. 
ribonucleases) and growth conditions. However, microarray-based studies on their own do 
not identify the site of action of ribonucleases. This would have required further analysis 
using techniques such as RNA-ligase mediated reverse transcription PCR, which identify 
differences in the pattern of 5’ ends. A ‘game changer’ was the implementation of RNA 
sequencing. Although used initially to map transcriptional landscapes via the sequencing of 
fragments generated by shearing of RNA following its isolation, it was evident that RNA-seq 
could also be used to map 5’ end fragments by incorporating an RNA ligation step before 
the shearing of the RNA (Figure 1.5). In such a way, Cynthia Sharma and co-workers 
mapped the transcriptional starts sites of Helicobacter pylori, but after removing 
degradation and processing intermediates by treating with TEX (Sharma et al., 2010). RNA 
ligation to the 5’-triphosphorylated ends of nascent transcripts was facilitated by treating 
with TAP. TAP treatments were performed by Vertis Biotechnologie AG (Germany), using 
the same enzyme supplier as the one used for the enzyme characterizations in Chapter 3. 
As indicated in the Introduction (Section 1.4), this paper provided the inspiration for the 
work described in this chapter, which describes the development of an alternative 
approach that, while still providing nucleotide resolution and differentiating sites of 
transcription initiation, simplifies the identification of the sites of processing and 
degradation. Comparison with results obtained previously validated this approach, which 
has been applied already to the study of other bacterial species. Within the E. coli genetic 
map, many new features were identified, such as previously undetected small RNAs and 
processing at a site associated with the production of specialised ribosomes, which may 
ensure the translation of leaderless mRNAs, which were also mapped. The approach also 
showed the benefit of incorporating steps that can differentiate the 5’ status of transcripts 
in assigning sites of transcription initiation. RNA sequencing was also used to map sites of 
cleavage by RNase E (see Chapter 3). Finally, just as topographic maps are only of value 
with the inclusion of contour lines, a meaningful context for the analysis of sites of 
processing and degradation was provided by also determining the profile of global 
transcription. 
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4.2 Results 
 Identification of transcription start sites 4.2.1
Prior to analysing the data collected for the cleavage of total RNA by the T170V mutant of 
RNase E (see Section 3.2.4), sites of transcription initiation and RNA cleavage were 
identified and differentiated on a genome-wide scale using a published approach (Lin et al., 
2013b) that was trialled as part of this work. These sites were then mapped against a 
transcriptional landscape map of E. coli generated from the same RNA sample using FRT-
seq (flowcell reverse transcription), a global mapping approach that is strand specific and 
free of amplification prior to sequencing (Mamanova et al., 2010). The RNA sample for 
these differential and global approaches was isolated from a wild-type strain, MG1655 
(seq) (Blattner et al., 1997), grown exponentially in Luria-Bertani medium. For dRNA-seq, 
total RNA was enriched for mRNA and then one half of the sample was treated with 
tobacco acid pyrophosphatase (TAP). Treatment with this enzyme removes pyrophosphate 
from nascent 5’ ends leaving a monophosphate group (Breter and Rhoads, 1979) to which a 
sequencing adaptor can be ligated in a subsequent step (Figure 4.1). Samples treated with 
or without TAP were then sent for sequencing as part of a service that also included the 
construction of the cDNA libraries. It should be noted that the RNA was fragmented after 
the addition of the 5’ adaptor to improve the efficient cloning of 5’ ends from large 
transcripts. Sequencing of each of the two libraries produced 3 to 9 million reads, which 
were mapped against the E. coli genome. For each position in the genome, the number of 
times it corresponded with the first nucleotide in a sequence read was counted. A 
significant increase in the number of sequencing reads at any position following TAP 
treatment provides an identifier of a transcriptional start site (TSS). For further details of 
this differential approach, see Section 2.5.5. 
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Figure 4.1 – RNA-seq pipeline used in this study. This figure presents the dRNA-seq and 
gRNA-seq approaches used in this study. On the left the dRNA-seq approach is illustrated 
with one sample being treated with tobacco acid pyrophosphatase (TAP) and the other not. 
On the right the gRNA-seq approach is illustrated. For a more detailed description refer to 
Figure 1.5. 
Sites enriched following TAP treatment were identified by analysing M-A (ratio-intensity) 
scatterplots (Figure 4.2). Two populations of values were found, as described previously for 
Propionibacterium acnes (Lin et al., 2013b). The largest population corresponds to sites of 
processing and degradation and it centres on a value of M close to 0, while the smaller 
population corresponds to TSSs, which are associated with higher M values. Nucleotide 
positions with M values above what was judged to be the upper boundary of the 
population corresponding to processing and degradation sites were designated as possible 
TSSs. Positions within 8 nt of each other were assigned to the same TSS, as it is known that 
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many promoters initiate transcription from a cluster of nucleotide positions (Salgado et al., 
2006). These sites were then mapped against leading edges of transcription, which were 
determined independently via manual inspection of the global RNA (FRT)-seq data (see 
Section 0), which had been processed at Leeds by Vijaya Mahalingam Shanmugiah. The 
reads from the global RNA-seq were trimmed and mapped to the genome, and for every 
position in the genome, the number of times it was read, irrespective of its position in 
individual RNA fragments, was counted and recorded in the format that allowed 
visualisation using the UCSC genome browser (Schneider et al., 2006; Chan et al., 2012). 
The upper range of the gRNA-seq reads was limited to make it easier to decipher their 5’ 
and 3’ boundaries, the transcription units becoming block-like in appearance. The main 
gene(s) of interest in any view are generally depicted left to right, and for genes on the 
reverse strand, the RNA-seq data are given negative values and are shown in red instead of 
black (for example, see Figure 4.3). 
 
Figure 4.2 - M-A scatterplots of values from the differential RNA-seq analysis. The M 
values correspond to Log2 (plus/minus) and A values to (Log2 plus + Log2 minus)/2, where 
minus and plus refer to the number of reads before and after treatment with TAP. For 
further details, see Materials and Methods (Section 2.5.5). The red line represents the 
upper boundary of the population of values corresponding to site of processing and 
degradation. The upper boundaries were placed manually to enclose the majority of the 
lower population, while taking into consideration the spread of M values scattered around 
0. The boundary was described by the polynomial equation                   
          . 
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Figure 4.3 - Example of sequencing visualization in the UCSC Microbial Genome Browser. 
This figure presents a screenshot of the UCSC genome browser (Schneider et al., 2006; 
Chan et al., 2012). Tracks depict, from top to bottom, the number of times each nucleotide 
position was the first in sequence reads after and before treatment with TAP (dRNA-seq 
data), the number of times each position was sequenced following fragmentation of the 
transcriptome (gRNA-seq), the position of annotated genes (protein and RNA coding, as 
appropriate). The bottom three tracks, which are represented in red, depict the same 
results as their forward strand (black) equivalents for the reverse strand. The numbers at 
the left of the RNA-seq tracks indicate the sequencing reads, whilst the topmost numbers 
indicate genome position. The labels at the very bottom represent the candidate TSSs 
which are marked by short vertical lines that are labelled to indicate the strand of DNA to 
which they correspond (FWD or RVS), the class to which they belong (I, II or III) in 
parentheses, and the position of the first nucleotide in the site. 
A total of 709 sites that were associated with leading edges of transcription as well as being 
enriched following TAP treatment (Class I), 311 that were associated with leading edges, 
but not enriched (Class II) and 1554 that were enriched, but not associated with leading 
edges of transcription (Class III) were identified. Although, Class I sites were assigned with 
the most confidence, being based on two criteria, all three classes contained TSSs that have 
been identified previously by others and recorded in RegulonDB (Salgado et al., 2006; 
Mendoza-Vargas et al., 2009a) (Table 4.1). This information has been included in the 
annotation of E. coli sites (Table S.1). The majority of the 5’ ends identified by dRNA-seq do 
not correspond to TSSs, consistent with a major role of endoribonucleases in the 
degradation of mRNA (see Introduction, Table 1.2). Examples of each class of TSS are 
shown in Figure 4.4. The probable basis of the different classes, which has been described 
previously by us (Lin et al., 2013a), is outlined in Section 4.3. 
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The genes for which TSSs are presented in Figure 4.4 are: thrL which is the leader of the 
thrLABC operon that encodes four of the five enzymes involved in the threonine 
biosynthesis pathway (Gardner, 1982); talB which encodes transaldolase B (Sprenger et al., 
1995) and gapA which encodes glyceraldehyde 3-phosphate dehydrogenase A monomer 
(Charpentier and Branlant, 1994). As discussed later, enrichment in the absence of an 
obvious step increase in transcript abundance (Class III) and a step increase in transcript 
abundance in the absence of enrichment (Class II) are a result of promoters nested 
downstream of strong promoters and efficient 5’ pyrophosphate removal in vivo, 
respectively (Celesnik et al., 2007; Deana et al., 2008; Richards et al., 2011). All of the TSSs 
identified here have been annotated to indicate whether or not they have been identified 
previously using experimental approaches. 
TSS Class Number of TSSs 
identified 
Overlap with 
RegulonDB TSSs 
Percentage overlap 
Class I 709 298 42 
Class II 311 79 25.4 
Clas III 1554 197 12.7 
Total 2574 574 22.3 
Table 4.1 - Overlap of TSSs identified with TSSs recorded in RegulonDB. Number of class I, 
II, and III TSSs identified by our approach are presented along with and their percent 
overlap with RegulonDB TSSs which have experimental evidence to support them.  
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Figure 4.4 - Examples of different classes of transcription start site. All of the TSSs shown 
in this figure have been previously identified via experimental approaches. Panels A, B and 
C show the TSSs of E. coli genes thrL (Gardner, 1982; Lynn et al., 1987), talB (Sprenger et 
al., 1995) and gapA (Charpentier and Branlant, 1994) which correspond to a class I, class II 
and class III TSSs, respectively. The panels are screenshots from the UCSC Microbial 
Genome Browser (Schneider et al., 2006). Labelling is as in Figure 4.3. 
Our dRNA-seq approach was validated by retrieving the sequences upstream of known TSSs 
for genes associated with the translational machinery. The vast majority of the sequences 
could be aligned, using MEME (Bailey et al., 2009), with the consensus sequences for the -
35 and -10 boxes of vegetative promoters (TTGACA and TATAAT), which are recognised by 
the housekeeping RNA polymerase (Harley and Reynolds, 1987; Lisser and Margalit, 1993) 
(Table 4.2). Indeed the consensus sequence for the promoters aligned here was identical to 
that described previously (Figure 4.5). It also revealed a GC-rich heptanucleotide region 
immediately downstream of the -10 box which would correspond to the GC rich region 
which flanks the -10 box (Dickson et al., 1975; Hsu et al., 1984). The analyses described 
gave confidence that the dRNA-seq approach could identify TSSs and prompted similar 
analysis of equivalent dRNA-seq data for P. acnes (Lin et al., 2013b) and S. coelicolor 
(unpubl. data). 
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Table 4.2- Table showing the upstream region of the sites of enrichment for tRNA and rRNA TSS.  
Suggested operon TSS position Enrichment Strand Sequence 
rrsH-ileV-alaV-rrlH-rrfH-aspU 225017 4.20 + TCATGGCCCTTACGACCAG   GGCTACACACGTGCTACAATGGCGCATACA 
aspV 236910 13.95 + GAAAAACCGTTGACGAAGG    TCGAGGCAATCCGTAATATTCGCCTCGTT 
Pseudo  344476 5.50 + ATGTGTTGGTTGACATTCA        TATGAAAAAAATCATAATTCCATCA 
argU 563921 10.50 + CAAAAGCCATTGACTCAGA      AGGGTTGACCGTATAATTCACGCGATT 
infA-serW 925908 9.86 - TGAATGTTTTCGGCACATT      TCTCCCCAGAGTGTTATAATTGCGGTC 
serX 1096903 18.50 - AAAAGTTTGTTGACCTCAG    GTCATGATTTCCCTAAATTAGCGCCCGTT 
glyW-cysT-leuZ 1990208 23.77 - AAAATATCGTTGACTCATC     GCGCCAGGTAAGTAGAATGCAACGCATC 
serU 2041590 4.49 - CAGGGACTGTTAAAATGCC     AAATTTCCTGGCATCATGGCAACCATCT 
asnT 2042562 31.50 + AATTTAGTGTTGACAGACA    AGGTACCGCTAAGTAATATTCGCCCCGTT 
asnW 2056138 19.53 - AAACAGGCTTTGACATTGT    GGGTGGGCATCGCTAATATTCGCCTCGTT 
snU 2057866 12.38 + AAATCGGGTTTGACAAAAG     ATTTTTCGCCGTTAAGATGTGCCTCAAC 
asnV 2060273 19.77 + TTTCACCCTTTGACATCAC    CATGCACTGCCATTAATATGCGCCCCGTT 
proL 2284227 18.86 + ATATCTTACTTGCAATCGG  TGTGGAAAACGGTAGTATTAGCAGCCACGAG 
alaW-alaX 2516279 19.25 - AATTTGCCGTTGACACATT    CGGGCGGAATTCATATGATGCCGCCCGTC 
valU-valX-valY-lysV 2518944 11.21 + GAAAATGCGTTGACTCATT     TTGAACTCTCCCTATAATGCGACTCCAC 
rrsG-gltW-rrlG-rrfG 2727935 5.92 - TCATGGCCCTTACGACCAG   GGCTACACACGTGCTACAATGGCGCATACA 
rrsG-gltW-rrlG-rrfG 2729661 6.63 - CAGCAAATACTGTCTGGTG    AATTGGTTCCGGGTAAAGTGATTCGCCTG 
ssrA 2753608 10.22 + CATTGAGGCTGGTCATGGC   GCTCATAAATCTGGTATACTTACCTTTACA 
serV-argV-argY-argZ-argQ 2816723 27.73 - AAAAATTGTTTGACTTATA     AGTCTCAGAAAGTAATATGTGCGCCACG 
glyU 2997092 15.57 - GCGTGGCACTTGCTAAGGA     GAGCGTAAGGTTTATAATGCCTTACGCA 
pheV 3108325 5.56 + TGCCTGACAATGCGTGCAATATCGGCAAAGTGATGATAGATTGTGCAGTCTG 
pheV 3108385 35.08 + GAAATTTGATTGACGAGAC    GAGGCGAATCAGGTTTAATGCGCCCCGTT 
MetCAT 3213618 13.50 + ATGGCTGGATTGCGACACG        GAGTTACTTTATAATCCGCTACCAT 
leuU 3320658 7.06 - ACATCGGTTTTGCTGTTTT    TTTCCGCAGTTGATACAATGCGATAAAAT 
rplM-rpsI 3376832 21.69 - AAAAAGGGGTCGATCTTTG    ACCCCGACTTCTCTATAATCCTGCGACCC 
rrsD-ileU-alaU-rrlD-rrfD-thrV-rrfF 3424407 5.27 - GTGAGCTCGATGAGTAGGG     CGGGACACGTGGTATCCTGTCTGAATAT 
rrsD-ileU-alaU-rrlD-rrfD-thrV-rrfF 3425540 4.33 - TCATGGCCCTTACGACCAG   GGCTACACACGTGCTACAATGGCGCATACA 
rpsL-rpsG-fusA-tufA 3469747 8.90 - ACCATGACGTTGACTCCTC       TGAACTGGCGTTTAAACTGGCTGCTT 
proK 3706721 3.44 - ATTAAGGGATTGACGAGGG    CGTATCTGCGCAGTAAGATGCGCCCCGCA 
selC 3834221 24.00 + TGGGGGATGTAGAAACTCA       AGGAAGTAGCTATAATGCGCCCCGCC 
rrsC-gltU-rrlC-rrfC-aspT-trpT 3941078 9.41 + TCATGGCCCTTACGACCAG   GGCTACACACGTGCTACAATGGCGCATACA 
rrsA-ileT-alaT-rrlA-rrfA 4033382 43.00 + AATAAATGCTTGACTCTGT     AGCGGGAAGGCGTATTATGCACACCCCG 
rrsA-ileT-alaT-rrlA-rrfA 4034801 10.43 + TCATGGCCCTTACGACCAG   GGCTACACACGTGCTACAATGGCGCATACA 
rrsB-gltT-rrlB-rrfB 4165929 9.81 + TCATGGCCCTTACGACCAG   GGCTACACACGTGCTACAATGGCGCATACA 
rrsB-gltT-rrlB-rrfB 4166279 8.20 + AAGCGTACTTTGTAGTGCT CACACAGATTGTCTGATAGAAAGTGAAAAGCA 
thrU-tyrU-glyT-thrT 4173404 16.07 + ATTTTTTAGTTGCATGAAC    TCGCATGTCTCCATAGAATGCGCGCTACT 
rrsE-gltV-rrlE-rrfE 4207417 11.58 + TCATGGCCCTTACGACCAG   GGCTACACACGTGCTACAATGGCGCATACA 
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Table 4.2 (continued) 
Suggested operon TSS position Enrichment Strand Sequence 
pheU 4360653 19.42 - GAAATTAGGTTGACGAGAT    GTGCAGATTACGGTTTAATGCGCCCCGTT 
glyV-glyX-glyY 4390333 11.50 + TTTGGGGGGTTGCAGAGGG     AAAGATTTCTCGTATAATGCGCCTCCCG 
Table 4.2- Table showing the upstream region of the sites of enrichment for tRNA and rRNA TSS. tRNA and rRNA genes which are in close 
proximity and or which gRNA-seq data showed were transcribed as a single unit are presented as “Suggested operons”. TSS loci are also 
presented alongside the strand and enrichment for each of these suggested operons. Sequences upstream of the +1 nucleotide (marked red) 
were aligned. Nucleotides present around the -10 region and matching the -10 (TATAAT) consensus sequence, as well as those in the -35 
region matching the -35 (TTGACA) consensus sequence, are highlighted in grey. 
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Figure 4.5- Weblogo generated following manual alignment of tRNA TSSs identified by 
the approach here presented. Conserved sequences in the promoters associated with 
genes encoding the translational machinery. This figure presents Weblogo represented 
(Crooks et al., 2004) changing the length of the spacer of individual promoters to maximise 
the alignment of the -35 box. The combined height of nucleotide symbols shows the level 
of sequence conservation at a particular position, while the height of individual symbols 
within a stack of nucleotides indicates the relative frequency at that position. The 
nucleotide positions are numbered relative to the average position of TSSs and no labelling 
is present where the spacer was introduced or no consensus was present. Strong 
conserved sequences can be observed at sites that would correspond to the -10 and-35 
boxes (TATAAT and TTGACA respectively). 
 Leaderless mRNAs and ribosome processing 4.2.2
Having access to nucleotide-resolution transcriptional maps annotated to show the 
positions of sites of transcription initiation and RNA processing and degradation allowed a 
genome-wide survey of aspects of gene expression and regulation. For example, it was 
found that in stark contrast to P. acnes (Lin et al., 2013b), E. coli MG1655 (seq) has only a 
few mRNAs that lack or have a short 5’ leader (<10 nt) and thereby cannot be translated via 
the canonical Shine-Dalgarno (SD) interaction (Shine and Dalgarno, 1974; Shine and 
Dalgarno, 1975). It increasingly appears that different species of bacteria differ 
substantially in the extent to which they use the SD interaction to initiate translation 
(Nakagawa et al., 2010). While a gene ontology analysis of the ‘leaderless’ P. acnes mRNAs 
failed to identify enrichment of a particular function(s) (Lin et al., 2013b), 3 of the 5 
leaderless E. coli mRNAs encoded repressors of prophage (Qin, Rac and e14). This extends 
the association between leaderless mRNA and repressors of mobile genetic elements in E. 
coli, which has been a major bacterial model for the study of ‘leaderless’ translation (Moll 
et al., 2002; Malys and Mccarthy, 2011). The two best-studied leaderless mRNAs in E. coli 
encode the cI repressor of bacteriophage lambda (Walz et al., 1976) and the TetR repressor 
of transposon Tn1721 (Baumeister et al., 1991). Neither lambda nor Tn1721 are present in 
the MG1655 (seq) strain of E. coli studied here. The two other E. coli mRNAs identified as 
being leaderless (Figure 4.6) encode housekeeping proteins, the RhlB helicase and 
phosphatidylglycerophosphatase A (PgpA). The former is a component of the RNA 
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degradosome, which as described earlier is central to both the processing and degradation 
of RNA (Carpousis et al., 2009), while the latter is involved in the biosynthesis of 
phospholipids (Lu et al., 2011). The start codon of rhlB has been confirmed by N-terminal 
sequencing of its product (Py et al., 1996). The leaderless mRNAs described above were 
identified by using the VLOOKUP function of Excel to identify TSSs that were associated 
with start codons no more than 10 nt downstream (Table 4.3). If the analysis was extended 
to start codons within a 20 nt leader, another 15 potential leaderless mRNAs would be 
identified. In all 15 of them, ribosome binding sites were not detected using the RBSfinder 
software (Suzek et al., 2001). However, leaders of between 10 and 20 nt could enable SD-
type interactions 
A 
 
B 
 
Figure 4.6 – pgpA and rhlB leaderless mRNAs. Panels A and B correspond to the pgpA and 
rhlB transcript respectively. Their TSSs are both class I and fall within 10 nt of the +1 site (in 
relation to translation) Labelling as in Figure 4.3. 
Gene  Start 
position 
Stop 
position 
Closest TSS Distance Function 
pgpA (+) 435812 436331 FWD(I)-435804 -8 Phosphatidylglycerophosphatase A 
ymfK (-) 1202156 1201481 RVS(I)-1202156 0 e14 prophage; repressor protein phage e14 
racR (-) 1418265 1417788 RVS(I)-1418265 0 Rac prophage; predicted DNA-binding 
transcriptional regulator 
dicA (+) 1645957 1646365 FWD(I)-1645954 -3 Qin prophage; predicted regulator for DicB 
rhlB (-) 3963653 3962387 RVS(I)-3963653 0 ATP-dependent RNA helicase 
Table 4.3 - Leaderless mRNAs. This table presents the 5 mRNAs which were identified as 
being leaderless. From left to right, columns represent the gene name and direction in 
brackets, start and end codons followed by the closest TSS detected and the relative 
distance between this TSS and the annotated start codon. The known function for each 
gene is also presented. 
Recently, it has been shown that leaderless E. coli mRNAs specifically generated by 5’ 
trimming under conditions of stress are translated by specialised ribosomes from which the 
last 43 nt of the 3’ end of 16S rRNA have been removed endonucleolytically (Vesper et al., 
2011). This region contains the anti-SD sequence and the binding site of S1 (Shine and 
51 
 
Dalgarno, 1974; Lauber et al., 2012), a ribosomal protein that augments the SD interaction 
(Sorensen et al., 1998). This work prompted me to look for evidence of 3’ processing of 16S 
rRNA in our RNA-seq data. Processing precisely 43 nt from the 3’ end of E. coli 16S rRNA 
was detected (Figure 4.7). It is possible that specialised ribosomes similar to those 
generated during stress could facilitate the translation of the handful of leaderless mRNA 
present in E. coli during exponential growth, and that by the virtue of being leaderless the 
mRNA might be pre-programmed to be translated efficiently during conditions of stress 
when increasing numbers of specialised ribosomes are produced. For example, the 
continued repression of phage genes would be required to prevent premature cell death. 
 
Figure 4.7 - 16S rRNA MazF equivalent cleavage site. This screenshot presents the 3’ end 
of the 16S rRNA from the rrnE operon. The site where MazF mediated cleavage normally 
occurs is indicated by the legend “-43 nt”. Labelling as in Figure 4.3. The only dRNA-seq 
track shown is “TAP plus” as there is no enrichment and “TAP minus” is identical to it. 
 The maturation of stable RNAs 4.2.3
The study of E. coli and to a lesser extent B. subtilis has revealed that mature ribosomal 
RNAs are produced via a series of nucleolytic steps involving several ribonucleases and that 
rRNA can be degraded in response to aberrant assembly of the ribosome or cellular stress 
(Deutscher, 2009). Remarkably, it was possible to detect for E. coli most of the known 
endonucleolytic processing sites, despite the transitory existence of the corresponding 
intermediates. All five of the known endonucleolytic steps that produce the mature 16S 
rRNA via the combined activities of RNases III, E and G and an as yet an unidentified 
nuclease, possibly RNase YbeY (Jacob et al., 2013), were detected (Young and Steitz, 1978; 
Li et al., 1999a; Wachi et al., 1999), as well as the RNase III cleavages involved in the 
maturation of 23S rRNA (Bram et al., 1980), and a tight cluster of cleavages that produce 
the 5’ end of 5S rRNA, at least one of which is produced by RNase E (Misra and Apirion, 
1979). Data shown is for the rrnE operon, but is representative of all seven E. coli operons 
(Figure 4.8). Several prominent sites internal to the rRNA and on the 3’ side of tRNA 
internal to rRNA operons were also detected. Sites at the precise 3’ ends of 23S and 5S RNA 
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were not detected as these are generated via 3’ exonucleolytic trimming by RNase T (Li et 
al., 1998). Cleavage at a large number of sites internal to the functional regions of the 
mature rRNAs was also observed for P. acnes (Lin et al., 2013b). These nucleolytic events 
may control the quality of rRNA (and ribosomes) (Jacob et al., 2013), prevent rRNA 
accumulating in excess over ribosomal proteins (Norris and Koch, 1972; Gausing, 1977) or 
mediate the rapid turnover of prematurely terminated transcripts, which may occur more 
frequently in rRNA operons (Condon et al., 1995), or a combination of these. Moreover, the 
high density of nucleolytic sites in E. coli where there is no known 5’ exoribonuclease, 
indicates the use of endoribonucleases on a scale perhaps not appreciated previously. 
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Figure 4.8 - Processing of the rrnE operon. This figure presents the rrnE operon (b4007, b4008, b4009 and b4010 which correspond to 16S rRNA, Glu tRNA, 
23S rRNA and 5S rRNA respectively). Panel A shows the whole rrnE operon; red boxes labelled B, C, D and E are regions that were resolved to a higher 
degree, thus the decrease in the scale for panel D, and correspond to the panels B, C, D and E, respectively. Cleavage sites for RNaseE, G and III are labelled 
E, G and III respectively whilst sites for which a ribonuclease is yet to be identified are labelled “?” Labelling as in Figure 4.3 with the exception that the scale 
in the “TAP plus” lane in Panel A is variable with the 0-2000 scale regions highlighted grey and the 0-25000 scale regions showing no highlighting. 
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E. coli has been a major model for studying the processing of tRNAs. This study has led to 
the establishment of the model in which the mature tRNA 5’ end is generated by the 
ubiquitous endonuclease RNase P, and the mature 3’ end via endonucleolytic cleavage a 
few nucleotides downstream the CCA motif followed by 3’ exonucleolytic trimming to this 
motif. The CCA motif is present in all of the 86 tRNA genes in E. coli. The maturation of the 
3’ end can be mediated by RNase BN (known as tRNase Z in other bacteria species), which 
has dual endo/3’ exonucleolytic activity (Dutta and Deutscher, 2010; Dutta et al., 2012), or 
by the combined action of RNase E and 3’ exonucleases, mainly RNases PH and T 
(Hartmann et al., 2009). Fully consistent with this model, in all cases where 5’ and 3’ 
processing sites could be detected for tRNAs, they were at the precise 5’ end and within a 
few nucleotides downstream of the 3’ end of E. coli tRNAs, respectively (Table 4.4). In 
contrast, the analysis of P. acnes found that most of the CCA-encoding tRNAs are cut within 
this motif between the Cs (Lin et al., 2013b). It is likely that, for P. acnes, the homologue of 
tRNA nucleotidyltransferase (SCO3896), which adds CCA to tRNAs not synthesised with this 
motif (Cudny and Deutscher, 1986), can recognise partial CCA ends and add only the 
residues that are missing. There is evidence that at least some tRNA 
nucleotidyltransferases, including the E. coli enzyme (Reuven et al., 1997), have the 
capability of repairing CCA (Betat et al., 2010). Such an activity in P. acnes would mean that 
cleavages within 3’ CCA triplets would not result in terminal inactivation of the tRNA.  
tRNA Strand 5' end 3' end 
3' cleavage 
site 
ArgACG - 2816571 2816494 CCAt↓at 
AspGTC + 236930 237007 CCA↓c↓ta 
AspGTC + 3944894 3944971 CCAccct↓a↓at 
CysGCA - 1990011 1989937 CCA↓c↓ttt↓ct 
GlnCTG - 695839 695764 CCAa↓ttt↓at 
GlyGCC - 1990141 1990065 CCAg↓tt 
HisGTG + 3980532 3980608 CCAtt↓at 
MetCAT - 695963 695886 CCAa↓at 
SerGCT - 2816667 2816574 CCAttt↓gc 
ThrGGT - 3421677 3421601 CCActt↓tt 
TyrGTA - 1286845 1286760 CCAta↓at 
TyrGTA + 4173494 4173579 CCA↓a↓tt 
Table 4.4 - Processing of tRNA genes in E. coli. tRNA genes for which 3’ processing was 
detected are presented alongside their respective start and end positions and their strand. 
Cleavage/s detected within the 10 nt downstream of the terminal CCA at the 3’ end of each 
tRNA are indicated with an arrow within the sequence where they occur. 
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 The degradation and processing of mRNA 4.2.4
With regard to mRNA, endonucleolytic sites involved in both the degradation and 
processing of E. coli mRNA were detected (Figure 4.9). This included RNase E sites that 
accelerate the turnover of eno (Kime et al., 2008a), rpsT (Coburn and Mackie, 1998) and 
ompA (Rasmussen et al., 2005) mRNAs by providing additional ends for 3’ exonucleolytic 
attack. Additionally RNase III sites were detected in the 5’ leader of adhE and pnp mRNA 
that facilitate translation (Aristarkhov et al., 1996) and an autoregulatory mechanism 
(Jarrige et al., 2001), respectively as well as RNase P sites that segment polycistronic 
mRNAs (Lee et al., 2008). In addition, previously uncharacterised cleavage sites within 
mRNAs that serve as models for understanding mRNA degradation, e.g. one internal to the 
coding region of rpsT mRNA and another that removes the 3’ stem-loop of ompA mRNA, 
were detected. Thus, our RNA-seq approach not only confirms, but extends knowledge of 
events controlling the activity and longevity of mRNA in E. coli.  
A 
 
B 
 
C 
 
Figure 4.9 - Detection of known cleavage sites. This figure presents the differential and 
global sequencing profiles for three characterized genes. Panel A presents eno where the 
RNase E site at position -27 is marked with an E. Panel B presents ompA, the RNase E 
cleavage site at -66 nt is labelled E and the promoter RVS(I)-1019410. Panel C presents rpsT 
where the two promoters are labelled RVS(I)-21211 and P2. A novel, previously unidentified 
cleavage site is labelled U whilst the RNase E cleavage sites occurring at positions +167 and 
+210 are labelled E1 and E2 respectively. All positions are in relation to the first nucleotide 
in the start codon. All labelling is as in Figure 4.3. As cleavage site reads are similar in TAP 
treated and TAP untreated samples only the track presenting the best peaks for both TSSs 
and cleavage sites are presented. 
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 Identification of potential sRNAs 4.2.5
Manual inspection of the global RNA-seq data identified 181 small RNAs (Table S.2) of 
which 87 appear to have been described previously (Figure 4.10). Within this group, the 
ubiquitous bacterial sRNAs, 6S RNA, tmRNA, the RNA component of RNase P, and Signal 
Recognition Particle RNA (Lee et al., 1978; Vioque et al., 1988; Struck et al., 1990; Felden et 
al., 1997; Schneider et al., 2006; Chan et al., 2012) were all readily identifiable (Figure 4.11). 
Of the remaining 89, many had 5’ ends associated with Class I or III promoters (TAP 
enrichment) indicating that this group was not dominated by quasi-stable processing or 
degradation intermediates. However, 69 were associated with REP (repetitive extragenic 
palindromic) sequences, which are found peppered throughout the genomes of bacteria. 
REP sequences have been shown to efficiently block the progression of 3’ to 5’ 
exonucleolytic attack (Stern et al., 1984; Newbury et al., 1987). Thus, small RNAs 
overlapping with a REP sequence were also filtered out. It is acknowledged that this may 
have excluded functional small RNAs that happen to utilise REP sequences to increase their 
stability. However, collaborators were concerned, perhaps overly, that others would simply 
interpret the presence of a REP as evidence for quasi-stable processing or degradation 
intermediates. Moreover, transcripts shorter than 70 nt were not included in our list of 
small RNAs. This was done to exclude 3’ transcriptional terminators, which like REP 
sequences, form stem-loop structures that are less susceptible to 3’ to 5’ exonucleolytic 
attack (Andrade et al., 2009). Another reason for eliminating transcripts shorter than 70 nt 
was to eliminate artefacts caused by the misalignment of short reads. Where sequences 
are duplicated in the genome (e.g. ribosomal RNA operons), the alignment algorithms 
assign reads to them on a random basis. This can produce features which look like 
‘chimneys’ of transcription in genome-wide transcription maps when a read from a highly 
transcribed region is assigned to a region that is not. After filtering out small RNAs that had 
been described previous or were associated with REP sequences, 20 small RNA remained. 
Examples of these novel small RNAs are shown in Figure 4.12.  
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Figure 4.10 - Venn diagram presenting sRNAs identified in our study, previously identified 
sRNAs and REP sequences. This Venn diagram presents the 181 sRNAs detected by our 
sequencing approach (labelled “sRNAs detected by our approach”). It also presents the 444 
sRNAs that have been previously described in the literature and have experimental 
evidence associated with them (labelled “Published sRNAs”). There is an overlap of 87 
sRNAs between our data and the published data. Regarding overlap with REP sequences 
(labelled “REP sequences”) our data contains 69 sRNAs with REP sequences whilst the 
published dataset contains only 4. 
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Figure 4.11 - Previously identified sRNAs supported by our sequencing approach. This 
figure presents the ubiquitous bacterial sRNAs, 6S RNA (Panel A), the RNA component of 
RNase P (M1RNA) (Panel B), Signal Recognition Particle RNA (Panel C) and tmRNA (Panel D). 
Labelling is as in Figure 4.3.  
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Figure 4.12 - Novel candidate sRNAs identified by our sequencing approach. This figure 
presents four novel sRNA candidates (panels A to D). Labelling in parentheses indicates 
whether the sRNA is upstream (u) or downstream (d) of the nearest protein-coding gene 
and whether it is on the same (+) or opposite (-) strand. The prefix 'ecr' is used for discrete 
RNAs of unknown function. The remaining of the labeling is as in Figure 4.3. 
 Mapping of sites of cleavage by T170V in vitro 4.2.6
After the generation of reliable maps with regard to transcription and the positions of sites 
involved in RNA processing and degradation, the results of incubating enriched mRNA with 
the T170V mutant (Figure 3.9) were analysed next. Libraries were prepared from aliquots 
of RNA isolated from the ΔrppH strain that had been incubated with and without T170V for 
20 min. This was done as described for dRNA-seq with the exclusion of the TAP treatment. 
For each of the libraries, the genome positions of the 5’-monophosphorylated ends were 
mapped and an estimate of the relative abundance of the corresponding fragments was 
obtained by counting the numbers of reads starting at each of the positions. Positions not 
associated with reads before and after incubation with enzyme were not included in the 
scatterplot. Where reads were obtained under only one condition (i.e. before or after 
incubation with T170V), the read for the other was given a nominal value of 1 (the lowest 
limit of detection). In this way, ~567 thousand ends were mapped. 
The reads obtained before and after incubation with T170V were then compared using M 
(ratio)-A (intensity) scatterplots, where M = Log2 (reads after/reads before incubation with 
T170V), and A = (log2 reads before + log2 reads after incubation)/2 (Figure 4.13). This 
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revealed a cone-shaped population of points that were distributed around an average M 
value of -0.43. This population corresponds to 5’-monophosphorylated ends that were 
present in the starting material and were not cleaved significantly. Above this population, 
there was a large ‘cloud’ of points of which 15 had M values greater than 10, 185 had M 
values greater than 8, 2667 had M values greater than 5 and 13551 had M values greater 
than 3. As the 5’ ends associated with transcripts that are rapidly degraded following in 
vitro incubation with T170V show a decrease in reads, a noise envelope could not be 
determined. Thus a cut-off where M values greater than 5, which correspond to a fold 
increase of 32 (2 to the power 5), were considered as being significantly enriched following 
incubation with T170V in vitro was used. Thus, despite being deficient in 5’-
monophosphate sensing, T170V appears to be able to cleave at a large number of sites in 
the E. coli transcriptome. The proportion of the cleavages mediated by T170V that are likely 
to be of functional significance was then estimated, by analysing the extent of the overlap 
between sites cleaved in vitro and those identified in vivo. This was done using the 
VLOOKUP function of Excel. For in vitro sites with M values of 3, 5 and 8, the percentage 
overlap with in vivo was 61.4, 72.1 and 75.7 % respectively. Thus, while RNA binding 
proteins block access in vivo to sites that were available to RNase E in vitro, it appears, 
nevertheless, that direct entry by RNase E may mediate a substantial number of cleavages 
detected in vivo. Moreover, this is likely to be an underestimate as detection of cleavages 
in vitro requires that the substrate is present at sufficient levels in vivo, against a 
background of active processing and degradation, and because some of the downstream 
species of RNase E cleavage might be degraded so rapidly that they cannot be detected in 
vivo. Examples of some top candidates where in vivo cleavage sites are reconstituted 
following in vitro incubation with T170V are presented in Figure 4.14. 
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Figure 4.13 - Scatterplot analysis of RNA-seq data following total mRNA incubation with 
T170V. The values corresponding to the reads obtained before and after the incubation of 
enriched RNA with T170V for 20 min. The points coloured blue have M values ≥5. 
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Figure 4.14 – in vivo cleavage sites reconstituted in vitro following incubation with T170V.  
This figure presents four top examples of cleavage sites (labeled *) which are present in 
vivo (T170V minus) and are reconstituted when total mRNA in incubated with T170V in 
vitro (T170V plus). The examples presented are 5S rRNA, dnaK, fumA and manX (Panels A, 
B, C and D respectively). Scales are different in the T170V minus and T170V plus tracks. 
Labelling is as in Figure 4.3 
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4.3 Discussion 
This chapter describes the successful development of a pipeline that utilises RNA-seq to 
map the location of sites involved in RNA processing and decay (Figure 4.1) against the 
transcriptional landscape present under the same conditions and to investigate the 
contribution of direct entry cleavage by RNase E using the T170V mutant (Figure 4.13). The 
results of the latter suggested that one of the hallmark properties of RNase E, i.e. its ability 
to interact with 5’-monophosphorylated ends, is not required for efficient cleavage at a 
plethora of sites within the E. coli transcriptome (Figure 4.13). Consistent with this notion, a 
selection of 5’-triphosphorylated transcripts was found to be cleaved by the T170V mutant 
in vitro (see Chapter 5). 
Previous RNA-seq analyses of sites involved in bacterial gene regulation have had a 
different focus, concentrating instead on the identification of transcription start sites. As 
described in the Introduction (Section 1.4), TSSs in previous studies were identified by 
removing the 5’-monophosphorylated products of RNA processing and degradation and 
then treating the remaining RNA with TAP to allow the cloning of fragments corresponding 
to the 5’-triphosphorylated ends of nascent transcripts (Figure 1.5). The approach 
described here, which took advantage of the ability of Illumina Solexa sequencing to 
generate ~10 million reads per run, also identified TSSs, but by virtue of the increase in the 
number of the corresponding reads that followed treatment with TAP. Sites involved in 
RNA processing and degradation, which show no such increase, provided a clear baseline 
for identifying TSSs (Figure 4.2) as well as sites cut by T170V in vitro (Figure 4.13). In a 
recent study of the E. coli transcriptome that did not include a step to differentiate TSSs, 
sites of processing as determined here, some of which are well characterised and 
documented (e.g. RNase P maturation of the 5’ end of tRNA), were identified erroneously 
as TSSs (Cho et al., 2009). Moreover, the inclusion of a differential step is critical to identify 
transcription start sites that are positioned downstream of others that produce significant 
transcription. By widening the pipeline to include replicates and a statistical analysis that 
took into account the inherent noise in RNA-seq data, it was possible in a recent study of 
the transcriptional landscape of Propionibacterium acnes, a major contributor to wide-
spread human disease, to identify not only nested promoters upstream of coding regions, 
but sites that have been attributed to pervasive transcription (Cho et al., 2009; Georg et al., 
2009; Guell et al., 2009; Jacquier, 2009; Jager et al., 2009; Mendoza-Vargas et al., 2009b; 
Rasmussen et al., 2009; Toledo-Arana et al., 2009; Albrecht et al., 2010; Beaume et al., 
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2010; Dornenburg et al., 2010; Filiatrault et al., 2010; Marguerat and Bahler, 2010; Martin 
et al., 2010; Sharma et al., 2010; Wurtzel et al., 2010; Lasa et al., 2011; Mitschke et al., 
2011). The latter may be largely the consequence of the ability of RNA polymerases to 
initiate transcription from sub-optimal sequences (Lin et al., 2013b). 
As a result of the encouraging results described here, the use of TAP or another RNA 
pyrophosphatase as a means of distinguishing nascent 5’ ends is advisable. However, 
treatment with TEX may offer better discrimination of TSSs that correspond to transcripts 
that are efficiently ‘decapped’ by an RNA pyrophosphatase in vivo and as a consequence 
cannot be enriched significantly by TAP in vitro. In this scenario, TEX treatment would 
remove the majority of the species allowing those with nascent 5’ triphosphorylated ends 
to be detected. In this study, 311 leading edges of transcription for E. coli were detected, 
and although not associated with obvious enrichment (Class II sites), the majority had 5’ 
ends which were detectable by dRNA seq. Most of these TSSs were associated with 
extremely low A values (Figure 4.2). Furthermore, analysis of the corresponding 5’ ends did 
not identify terminal stem-loops, which are known to block RNA pyrophosphatases 
(Celesnik et al., 2007). Considered together, these results suggest that 5’ ends associated 
with leading edges of transcription were not identified by dRNA-seq as they could not 
compete with others during the PCR step. About 25% of the promoters recorded in 
RegulonDB (Salgado et al., 2006) that have been verified by transcript-specific mapping 
(e.g. nuclease protection or primer extension assays) and were associated in this study with 
obvious transcription extending downstream (data not shown) were assigned to Class II.  
In addition, background transcription could explain at least a proportion of the TSSs in Class 
III, which are associated with TAP enrichment, but not an obvious step increase in 
transcription. However, verification of background transcription initiation will require a 
number of biological replicates and statistical analysis, as applied recently to P. acnes (Lin, 
2013) as the sequencing runs for the analyses here presented were done once and not in 
duplicate. TSSs associated with alternative promoters nested downstream of ones that 
produce a substantial increase in transcription were also assigned to Class III. This 
represents about 15-20% of the promoters recorded in RegulonDB (Salgado et al., 2006) 
that have been verified by transcript-specific mapping (e.g. nuclease protection or primer 
extension assays) and were associated in this study with obvious transcription extending 
downstream (data not shown). 
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The mapping of TSSs could be further improved by analysing strains which are deficient in 
the RNA pyrophosphatase; this might not always be desirable given the resulting changes in 
gene expression and presumably cell physiology accompanying this deletion. The addition 
of a phosphorylation step would allow the identification of the cleavage sites of RNases 
that produce downstream products with a 5’-hydroxyl group. This is likely to be particularly 
relevant to studies of conditions suboptimal for growth under which such RNases, e.g. 
MazF (Vesper et al., 2011), are activated. It is advisable that RNA is fragmented after the 
addition of the 5’ sequencing adaptor as this step made it possible to detect the 5’ ends of 
large and small transcripts, and the use of the FRT methods of global RNA-seq, which does 
not require an amplification step prior to sequencing (Mamanova et al., 2010). The latter 
may be of more importance in the study of GC-rich organisms such as the streptomycetes 
as their transcriptomes tend to form more stable secondary structures, which can 
introduce strong bias in assays involving PCR (Mcdowell et al., 1998).  
In relation to the 20 novel sRNAs identified, it is not believed that this group represents 
metastable decay intermediates, as most are associated with TSSs in Class I. Furthermore, 
as the expression of several sRNAs has been shown to be regulated by growth (Vogel et al., 
2003) and the RNA-seq was performed on RNA extracted from cells grown exponentially, it 
is expected that not all sRNAs in the literature will be detected. As a result of this, the 
overlap between our data and the library of sRNAs previously identified under a vast array 
of conditions is not as prominent as expected. 
New features within the transcriptome of E. coli, despite it being one of the most studied 
organisms, such as the 20 small RNAs that had been un-described previously (Table S.2 and 
Figure 4.10) and ribosomal RNA processing (Figure 4.7) that might produce a subpopulation 
of ribosomes during exponential growth that ensure the translation of the mRNAs, 
identified here, that are leaderless in their nascent form (Table 4.3) are discussed at the 
end of the Chapter 5. 
64 
 
Chapter 5 
5 Confirmation of features within the transcriptional landscape of E. 
coli. 
5.1 Introduction 
Bacteria not only have to be able to respond rapidly to changes in nutrient availability, they 
have to be able to survive periods of nutrient deprivation and other conditions that are not 
conducive to growth. For example, Mycobacterium tuberculosis, which causes tuberculosis 
(TB), one of the deadliest diseases ever to afflict mankind (Cruz-Knight and Blake-Gumbs, 
2013), can produce latent TB infections in which the bacterial cell is thought to exist in a 
non-replicating dormant state, from which it may later reactivate and cause disease 
(Sutherland et al., 1976; Manabe and Bishai, 2000; Lillebaek et al., 2002). Although much 
surrounding latent infection by TB remains elusive, the molecular mechanisms by which 
bacteria are able to initiate and maintain a non-replicating dormant state, which is called 
persistence, is beginning to emerge (Zahrt and Deretic, 2001; Betts et al., 2002; Singh et al., 
2006). Major advances in our understanding of bacterial persistence has emerged from the 
study of E. coli. These advances include the description of persister cells, even during 
exponential growth, as a result of stochastic fluctuations in gene expression that lead to 
phenotypic heterogeneity among cells within a clonal population (Elowitz et al., 2002; 
Davidson and Surette, 2008; Nikolic et al., 2013). Furthermore, the key role that toxin-
antitoxin (TA) systems play in mediating the persistent state across prokaryotes is also 
being elucidated (Wagner and Unoson, 2012; Schuster and Bertram, 2013; Butt et al., 
2014). 
The hallmarks of TA systems are a stable toxin that can inhibit an important cellular 
process, and an antitoxin that must be constitutively present in the same cell (Buts et al., 
2005; Gerdes et al., 2005). Although initially discovered as a mechanism associated with 
certain plasmids, that ensures only cells that continue to carry the plasmids survive 
(Bernard and Couturier, 1991; Thisted et al., 1994a; Thisted et al., 1994b), TA systems are 
now known to be encoded widely in the chromosomes of bacteria, where they are 
reported primarily to down-regulate cellular processes in response to stress rather than 
induce cell death (Yamaguchi and Inouye, 2009). However, this may be an overly simplistic 
view. Recently it has been shown that MazF, an endoribonuclease that serves as the toxin 
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component of a stress-induced TA system in E. coli, while destroying the majority of cellular 
transcripts, ensures the continued translation of a subset by cleaving at a site immediately 
upstream or close to their AUG start codon, thereby generating leaderless mRNAs (Vesper 
et al., 2011). Moreover, these leaderless mRNAs are translated by ‘specialised’ ribosomes 
that are also generated by MazF, via removal of 43 nucleotides from the 3' terminus of 16S 
rRNA, which is within the decoding centre of 30S ribosomal subunits (Vesper et al., 2011). 
The mRNAs that continue to be translated by the modified translation machinery are not 
just associated with cell survival but also cell death. It is thought that the induction of MazF 
leads to the death of most of the population and the survival of a small sub-population that 
can then expand when conditions become conducive to growth (Amitai et al., 2009). 
The ability of E. coli to adapt its physiology is now increasingly associated with the 
production of small RNAs. For example, the long-term survival of E. coli during stationary 
phase is enhanced by 6S RNA, which binds specifically to RNA polymerase containing 
sigma70 (Wassarman and Storz, 2000). This interaction represses transcription of the many 
housekeeping genes, thereby reducing the energy burden on the cell during stationary 
phase. Furthermore, sRNAs have been shown to block or enhance translation and mRNA 
degradation (see Section 1.3.3.1) 
In the previous chapter, RNA-seq analysis of the transcriptome of E. coli cells that were 
growing exponentially in rich media identified five mRNA transcripts that, in their nascent 
form, appear to lack a 5' leader sequence long enough to mediate a Shine-Dalgarno (SD) 
interaction, which is key to canonical translation in this model organism. Moreover, the 
processing site at the 3' end of 16S ribosomal RNA, the same as that cleaved by MazF, was 
detected. This raised the possibility that in rapidly growing cultures a subset of specialised 
ribosomes, similar to those generated during stress, could facilitate translation of 
leaderless mRNA transcripts. The RNA-seq analysis also revealed over a hundred small 
RNAs that appear not to have been described previously. This suggested that regulation by 
small RNAs may have a more extensive role than is currently appreciated. In this chapter, 
the existence of leaderless mRNAs under non-stress conditions, MazF-like processing of 16S 
rRNA, which further work by others implicates RNase E, and novel sRNAs are investigated 
further using techniques complementary to RNA-seq. 
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5.2 Results 
 Leaderless mRNA 5.2.1
RNA ligase-mediated reverse transcription PCR (RLM-RT-PCR, (Kime et al., 2008a)) before 
and after treatment with TAP was used to confirm the position of the 5’-triphosphorylated 
ends of leaderless mRNAs identified in the previous chapter (Table 4.3). The mRNAs of four 
genes were selected for this analysis: rhlB, pgpA, ftsT (also known as dicA) and ymfK. The 
first two encode RhlB, which is a core component of the degradosome (Miczak et al., 1996; 
Py et al., 1996), and a non-essential phosphatidylglycerolphosphatase (Icho and Raetz, 
1983; Funk et al., 1992), respectively. The second two encode repressors of genes within 
the Qin and e14 prophages (Keseler et al., 2013), respectively. RLM-RT-PCR involves the 
ligation of an RNA adaptor to the 5’ ends of transcripts, which can only occur if the 5’ end is 
monophosphorylated (Kime et al., 2008a). This was followed by reverse transcription of the 
RNA using random hexamers, and then the amplification of specific 5’-end fragment(s) 
using a primer that is specific for the transcript of interest and another specific for the RNA 
adaptor. The amplicons were then sequenced to identify the positions corresponding to the 
5’ end of the transcripts. Two different primers complementary to the RNA adaptor were 
used (RLM1 and RLM2, see Table 2.2). It was determined empirically if one or the other 
could facilitate better amplification when combined with gene-specific primers. The pgpA 
transcript was analysed using RLM1 and was predicted to produce an amplicon of 125 bp 
should it have a 5’ end that matches the site identified by RNA-seq (Figure 4.6). The rhlB, 
ftsT and ymfK transcripts were amplified using RLM2 and were expected similarly to 
produce amplicons of 156, 300 and 335 bp, respectively. The PCR products of ftsT and ymfK 
were analysed by electrophoresis using agarose gels whilst those of pgpA and rhlB were 
analysed using polyacrylamide gels (Figure 5.1). To differentiate 5’ ends that might 
normally be ‘decapped’ efficiently in vivo, RNA from an ΔrppH mutant as well as the 
congenic wild-type strain (BW25113) were analysed. Assays minus the ligation step were 
included as negative controls. 
All of the reactions produced amplicons of the expected size. However, in the case of rhlB, 
a second amplicon of ~230 bp was identified (Figure 5.1, panel D), which initially suggested 
the production of a leadered as well as leaderless transcript. For all of the transcripts, the 
abundance of the amplicons increased substantially following treatment of RNA from the 
ΔrppH mutant with TAP. This is consistent with the corresponding 5’ ends being the 
products of transcription initiation. Similar results were obtained using RNA from the wild-
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type strain, with the exception that the abundance of the amplicons produced for the 
leaderless ymfK and rhlB transcript did not increase following TAP treatment. This 
suggested that the ymfK and rhlB transcripts might be more efficiently decapped by RppH 
than the other transcripts under these conditions. Had a quantitative PCR been used to 
analyse the ligation product (Vanguilder et al., 2008), it might have been possible to 
discriminate the effects of TAP treatment. This was deemed unnecessary as the results of 
the RLM-RT-PCR analysis of RNA from the ΔrppH mutant agreed broadly with those of RNA-
seq. 
A 
 
B 
 
C 
 
D 
 
Figure 5.1 - Gel electrophoresis analysis of the products of RLM-RT-PCR Panels A, B, C and 
D correspond to the ymfK, ftsT, pgpA and rhlB transcripts, respectively. RNA extracted from 
BW25113 and ΔrppH (labelled accordingly) were either treated with TAP (labelled T) or left 
untreated (labelled U) prior to RLM-RT-PCR. Reverse transcription reaction samples were 
then PCR amplified and are labelled RT+ whilst their negative controls, which were not 
reverse transcribed, are labelled RT-. The expected products are labelled ymfK, ftsT, pgpA, 
rhlB 2 respectively; their sizes are indicated in brackets. For rhlB an unexpected product is 
labelled rhlB 1. The source of markers (labelled M) were the GeneRuler 100 bp Plus DNA 
Ladder (Fermentas) for panels A and B and the 10 bp DNA Ladder (Invitrogen) for panels C 
and D. The samples were electrophoresed on a 2% agarose gel (panels A and B) and 10% 
acrylamide (panels C and D). 
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The finding that rhlB produced a second amplicon of ~230 bp (Figure 5.1, panel D) was 
followed up by repeating the RLM-RT-PCR analysis, purifying the PCR products (without 
separating on the basis of size) and cutting with the restriction enzyme MseI. This enzyme 
cuts 87 bp upstream from the 3’ side of the binding site of the rhlB-specific primer (Figure 
5.2). Following digestion with MseI, two products consistent with the migration of this 87 
bp 3’ side fragment (P2) and its 69 bp 5’ side counterpart (P3) were detected; together they 
add up to the 156 bp fragment corresponding to the leaderless transcript (Figure 4.6). A 
faint product of ~230 bp was also detected (rhlB1), consistent with transcription also 
starting ~70 bp upstream of the start codon. However, the analysis was complicated by the 
presence of a species of ~70 bp of unknown identity, but probably a primer dimer from the 
RLM-RT-PCR reaction. Therefore, the rhlB amplicons of 156 and ~230 bp were gel purified, 
cloned and sequenced (Table S.3). The analysis of two independent clones of the smaller 
transcript confirmed that the 5’ end of this amplicon corresponded exactly to the +1 
position of rhlB (relative to the start codon), while the analysis of three independent clones 
of the larger amplicon positioned the second TSS at +70. The TSSs identified in this analysis 
are indicated in relation to gRNA-seq and d-RNA seq data (Figure 5.3). 
 
Figure 5.2 – Restriction enzyme digest of the rhlB RLM-RT-PCR products. RLM-RT-PCR 
products for rhlB before and after cleavage with restriction enzyme MseI (labelled U and 
MseI respectively). RLM-RT-PCR products prior to incubation with MseI are labelled rhlB 1 
and rhlB 2. Following restriction digest, the products are labelled P1, P2 and P3; their sizes 
are indicated in brackets. 
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Figure 5.3 - TSSs identified for rhlB following RLM-RT-PCR and cloning. RLM-RT-PCR 
results together with sequencing and restriction mapping indicate that rhlB possesses two 
TSSs, one of which is leaderless and another one that has a leader sequence of 70 nt. The 
mapping of these TSSs onto the genome browser view for rhlB are presented here. 
Labelling is as in Figure 4.3. 
 Specialized ribosome-like processing of 16S rRNA 5.2.2
As described in the Introduction to this chapter, the generation of specialized ribosomes in 
which the 43 nt at the 3’ end of the 16S rRNA containing the anti-Shine-Dalgarno sequence 
is removed via endoribonucleolytic cleavage by MazF has been recently described (Vesper 
et al., 2011). Cleavage at this site was also identified by RNA sequencing (Section 4.2.2), 
which is specific for 5’-monophosphorylated ends, not the 5’-hydroxylated ends generated 
by MazF and other mRNases associated with TA systems (Vesper et al., 2011; Cook et al., 
2013). To allow the basis of cleavage at the +43 site (relative to the 3’ end of mature 16S 
rRNA) to be studied specifically, RLM-RT-PCR was employed (Figure 5.4). However, the 
protocol was modified to allow good coverage of short RNA fragments by reverse 
transcription. The template produced by random priming could not be amplified using a 
gene-specific primer that binds to a site within the 43-nt segment but it could when reverse 
transcription was primed from the very 3’ end by adding a poly(A) tail and then using 
d(T)10(V) as a primer. The expected size of the amplicon corresponding to cleavage at the 
+43 site was 87 bp. Longer and shorter amplicons were also detected: this was not 
unexpected as cleavage sites upstream and downstream of the +43 position were detected 
by RNA-seq. The analysis included RNA isolated from a congenic ΔmazF strain during 
stationary phase as well as exponential growth. RNA was also treated with TAP and 
polynucleotide kinase, the latter to allow detection of 5’-hydroxylated ends. 
For the sample isolated from the wild-type strain during exponential growth, an amplicon 
of 87 bp was detected, albeit of low abundance, without treatment with TAP or PNK. This is 
consistent with the RNA-seq data. In the PNK-treated sample, the abundance of this 
amplicon was substantially higher indicating that much of the cleavage at this site 
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generates downstream product with a 5’-hydroxyl group. In other words, the RNA-seq 
approach only detected a minority of the cleavage at this site. The abundance of the 87-bp 
amplicon was also higher in the TAP-treated sample, although not nearly to the same 
extent as the PNK-treated sample. This suggests that the +43 site might also be associated 
with some transcription initiation. Analysis of the RNA from the ΔmazF strain during 
exponential growth produced a similar pattern to that of the wild-type strain, but with one 
clear exception: the abundance of the amplicon was not higher in the PNK-treated sample. 
This suggests that MazF normally cleaves at the +43 site in cultures in which the bulk of the 
cells are growing exponentially. For RNA from the ΔmazF strain during stationary phase, 
the detection of the 87-bp amplicon was dependent on PNK treatment. This suggests that 
an RNase other than MazF can cleave at the +43 site during stationary phase. The identity 
of the 87 bp amplicon was confirmed by cutting the products of the RLM-RT-PCR 
(untreated mazFex) with BstEII, which was predicted to produce fragments of 62 and 25 bp 
(Figure 5.5). Fragments with mobility consistent with the sizes of these products were 
detected. The significantly higher abundance of the 25 bp fragment reflects that it is also 
common to amplicons longer than the 87 bp (Figure 5.5). 
 
Figure 5.4 – RLM-RT-PCR analysis of cleavage at the -43 site of 16S rRNA. This figure shows 
the products generated following RLM-RT-PCR to detect cleavage at the -43 site of 16S 
rRNA. RNA extracted from BW25113, mazF at exponential growth (mazFex) and mazF 
at stationary growth (mazFst) were untreated (labelled U) or treated with TAP (labelled T) 
or PNK (labelled P). The expected 86 bp product is labelled on the right of the panel. 
Reverse transcription samples were PCR amplified and are labelled RT+ whilst their 
negative controls are labelled RT-. The samples were electrophoresed on a 10% 
polyacrylamide gel. 
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Figure 5.5 - Restriction assay of the 16S 3' end cleavage product. The 87 bp RLM-RT-PCR 
product generated by the cleavage at the 3’ end of 16S rRNA before and after cleavage 
with restriction enzyme BstEII (labelled U and BstEII respectively). The RLM-RT-PCR product 
prior to incubation with BstEII is labelled S. Following restriction digest, the products are 
labelled P1 and P2. Sizes are indicated in brackets. The gel is 10% polyacrylamide. 
 Confirmation of sRNAs by northern blotting 5.2.3
To verify the presence of small RNAs not described previously, at least to our knowledge, 
six of these sRNAs were selected randomly and probed using northern blotting under 
stringent conditions. RNA used for northern blot was separate from that used for RNA seq 
analysis. Moreover, as the expression of several sRNAs has been shown to be regulated by 
growth (Vogel et al., 2003), we isolated RNA from cells growing exponentially in M9 glucose 
as well as LB. As a control, we included the analysis of AgrB sRNA, which is an RNA 
regulator of the SOS-related DinQ protein (Weel-Sneve et al., 2013). Positive results were 
obtained for five of sRNAs and the AgrB control (Figure 5.6). The actual abundance of all of 
the detected sRNAs, apart from the AgrB control, was dependent on the growth media. The 
small RNA that could not be detected by northern blotting is identified as ecr0770(d-). 
Overall, the vast majority of sRNAs tested by northern blotting was detected. The northern 
blotting experiments were done in conjunction with collaborators, Olatz Ruiz Larrabeiti and 
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Vladimir Kaberdin (University of the Basque Country, Faculty of Science and Technology, 
Spain). 
 
Figure 5.6 – sRNA detection with radiolabelled probes. Northern blot results obtained by 
our collaborators. 30 µg of total RNA was extracted from MG1655, grown in LB and M9 
minimal media, and was blotted onto 6 nitrocellulose strips, each containing 5 µg total 
RNA. Each strip was then hybridized with 5 different radio-labelled oligonucleotide probes. 
The first strip was hybridized with an oligoprobe for AgrB and acted as a positive control. 
Following the control, from left to right, probes to detect sRNAs ecr0174(u+), ecr3777(d+), 
ecr4051(u+) and ecr1743(d+) were used and are labeled accordingly (for probe sequences 
see Table S.2). Markers are presented on the right and labelled M. 
 Confirmation of novel cleavage sites present in vivo reconstituted 5.2.4
following incubation of total mRNA with T170V in vitro. 
Using the RNA-seq approach described in the previous chapter, it was shown that the 
T170V mutant of RNase E is able to cleave at many sites within the E. coli transcriptome 
(Section 4.2.6). To investigate further whether these sites are cleaved efficiently by RNase E 
in the absence of binding to a 5’-monophosphorylated end, transcripts for a selection of 
candidates were synthesized in vitro and incubated with T170V. The selection was based on 
manual inspection of the RNA-seq data using a genome browser. Three mRNAs were 
selected dnaK, fumA and manX, as they were of average abundance (400-1500 reads, 
gRNA-seq data) and T170V cleavage occurred at sites mapped as being involved in 
processing or degradation in vivo. 5S RNA was included as a curiosity, as it is widely known 
as a product, not a substrate, of RNase E cleavage (Deutscher, 2009). The tRNA precursors, 
argX-hisR-leuT-proM, glyW-cysT-leuZ and pheU, were also included as a recent study by 
others had indicated that their processing in vivo was not dependent on the 5’ sensor of 
RNase E (Garrey and Mackie, 2011). 
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Using conditions described previously (Section 2.5.7), cleavage of 5’-triphosphorylated 5S 
RNA and dnaK mRNA by T170V and NTH-RNase E was readily detected (Figure 5.7, panels A 
& B). Based on the RNA-seq data, product sizes should be 120/55 and 214/238 nt, 
respectively. 5S RNA produced a cleavage profile that is consistent with a single cleavage 
site with product sizes being close to those expected. dnaK mRNA also shows significant 
cleavage but the number of products generated shows that an additional site which is not 
available in vivo is made available in vitro. The efficiency of these cleavages, as determined 
from the half-lives of the substrates, was similar to that reported previously for cspA mRNA 
(see Figure 3.8). These results confirmed that at least some, if not many of the sites 
identified by RNA-seq sequencing are cleaved efficiently by RNase E in the absence of 
binding to a 5’-monophosphorylated end, i.e. direct entry may be a major route by which 
processing and degradation occurs. Cleavage of manX and fumA (Figure 5.7, panels C and 
D) was also detected; however, it was much less efficient. Possibly, the corresponding sites 
were not within the conformational context in vitro that allowed cleavage in vivo. In 
support of this notion, efficient cleavage of cspA mRNA can be reduced substantially by 
certain truncations from the 5’ end, but then restored by further truncation (Kime et al., 
2010). A limitation of the RNA-seq approach is that while sites of cleavage can be identified 
readily, the 5’ and 3’ boundaries of the corresponding substrate(s) is not always obvious.  
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Figure 5.7 – Assay of RNase E direct entry candidates identified via in vitro reconstitution. 
The four RNase E direct entry mRNA candidates were incubated with NTH-RNase E and 
T170V. The reactions contained 0.64 µM of 5S RNA (A), dnaK mRNA (B) fumA mRNA (C) or 
manX mRNA (D) and 25 nM of wild-type NTH-RNase E or the T170V mutant. Samples were 
taken after 0, 5, 15, 30 and 60 min. A control of each mRNA, incubated alongside the 
cleavage assays without enzyme for 60 min, was also present (labelled C in all cases). 
Substrates are labelled 5S, dnaK, fumA and manX; cleavage products for each substrate are 
labelled *, ** or *** depending on the number of cleavages occurring within each 
transcript. Substrates for 5S RNA, dnaK mRNA, fumA mRNA and manX mRNA were 
generated by PCR and in vitro transcription with primer combinations 5SF/5SR, 
dnaKF/dnaKR, fumAF/fumAR and manXF/manXR, respectively (Table 2.2). All samples were 
analysed under denaturing conditions using a 7 M urea, 7% (w/v) polyacrylamide (19:1) gel. 
Incubation of the argX-hisR-leuT-proM precursor with NTH-RNase E and T170V produced a 
complex pattern of cleavage products that were similar, although not identical (Figure 5.8, 
panel A). Reaction conditions were consistent with those previously used (Section 2.5.7). 
The result described here suggested that the majority of the cleavages within the argX-
hisR-leuT-proM precursor were independent of 5’-monophosphate sensing. Consistent with 
this notion, subsequent experiments showed that the pattern and rate of cleavage was not 
altered dramatically when the 5’ end was treated to produce a monophosphate group 
(Kime et al., 2014). 
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Similar results to those described above were obtained for the glyW-cysT-leuZ precursor 
(Figure 5.8, panel B). Although initial cleavage does not appear to be dependent on 5’ 
sensing, an intermediate (labelled 2 in panel B) accumulated when incubated with T170V, 
but not NTH-RNase E. This suggests that, normally, this intermediate would be 
subsequently cleaved via a 5’-monophosphate-dependent step. Similar intermediates 
accumulated with the argX-hisR-leuT-proM precursor (labelled 2 and 3 in panel A). The 
pheU transcript was cleaved by T170V (Figure 5.8, panel C), but not as efficiently as the 
other precursors. This indicates that not all initial cleavages are necessarily mediated 
efficiently by direct entry. 
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Figure 5.8 – In vitro RNase E cleavage assays of tRNA precursors. tRNA operons argX-hisR-
leuT-proM and glyW-cysT-leuZ alongside the pheU transcript were incubated with NTH-
RNase E and T170V. The reactions contained 0.64 µM substrate argX-hisR-leuT-proM RNA, 
glyW-cysT-leuZ RNA and pheU RNA (Panels A, B and C respectively) and 25 nM of wild-type 
NTH-RNase E or the T170V mutant. Samples were taken after 0, 5, 15, 30 and 60 min. A 
control of each mRNA, incubated alongside the cleavage assays without enzyme for 60 min, 
was also present (labelled C in all cases). Substrates are labelled according to the first gene 
of the operon i.e. argX, glyW and pheU; cleavage products for each substrate are labelled 
with numbers depending on the number of cleavages occurring within each transcript. 
Shorter transcripts which were a result of the in vitro transcription and not of the cleavage 
assay are indicated with an asterisk. Substrates for the argX, glyW and pheU precursors 
were generated via PCR and in vitro transcription with primer combinations argXF/argXR, 
glyWF/glyWR and pheUF/pheUR, respectively (Table 2.2). All samples were analysed under 
denaturing conditions using a 7 M urea, 7% (w/v) polyacrylamide (19:1) gel. 
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After undertaking the comparisons described above, it was confirmed that the cleavage 
products generated by the N-terminal half of RNase E are the same as those produced by 
the RNA degradosome under conditions in which PNPase was not active (Louise Kime, 
unpubl.result). Others have also found that N-terminal half of RNase E is sufficient to direct 
all of the cleavages produced by the degradosome (Mackie, 2013a). The analysis of 5’ 
sensing described here was based on the NTH-RNase E rather than the degradosome, as 
our laboratory and its collaborators have so far been unable to purify degradosome 
preparations that incorporate RNase E with mutations in its 5’ sensor. 
5.3 Discussion 
In this chapter, the existence of leaderless mRNAs as well as the processing of 16S rRNA 
implicated in generating ribosomes capable of translating such mRNAs as well as the 
presence of small RNAs that were not previously described was demonstrated using RLM-
RT-PCR (Figure 5.1 and Figure 5.4) and northern blotting (Figure 5.6). Results concluded 
that the RNA-seq approach described in the previous chapter provides reliable maps of the 
transcriptional landscape that can be further annotated. With regard to the latter, 
preliminary analysis of in vitro cleavage sites mapped for T170V (Figure 5.7) confirmed that 
many are likely to be sites of cleavage that are mediated by direct entry rather than 
residual 5’-sensing activity.  
In addition to confirming the existence of leaderless mRNAs and 16S rRNA processing that 
is implicated in generating specialised ribosomes capable of translating such mRNAs, the 
RLM-RT-PCR analysis suggests that MazF also has a role in producing specialised ribosomes 
during exponential growth (Figure 5.4). Whether this is true for all cells within the culture 
or only a sub-population, and whether the level of processing determined is biologically 
relevant remains to be determined. The sensitivity of RNA-seq is such that potentially rare 
events, including pervasive transcription, can be detected. An assessment of biological 
relevance will require the integration of genetic approaches. For example, by engineering 
5’-leadered segments into the mRNAs of certain repressors of prophage (Qin, Rac and e14) 
and assaying for the release of phage into the culture, it would be possible to determine 
whether normally their leaderless status provides a simple mechanism by which their 
translation, and thus repression of the lytic cycle, is maintained during conditions of stress 
when increasing numbers of specialised ribosomes are produced. A detailed assessment of 
a ΔrhlB might shed light on why the mRNA of a degradosome component is leaderless. One 
possibility is that it is required for the remodelling of ribosomes following processing by 
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MazF and perhaps other ribonucleases. If this notion is correct, it might be expected that 
extracts from ΔrhlB would be less efficient at translating leaderless mRNAs in vitro. A role 
of RNA helicases in ribosome biogenesis is known (Jain, 2008). 
It would also be interesting to determine whether the RppH 5’ pyrophosphohydrolase has a 
role in the translation of leaderless mRNAs. Recent work has shown that the 5’-
phosphorylation status of the mRNA of the cI repressor of bacteriophage lambda might 
influence the efficiency of translation in vivo as well as the binding of ribosomes in vitro 
with a 5’-monophosphate group stimulating binding of the ribosome and thus translation 
(Giliberti et al., 2012). As of yet, no one else seems to have realised that 5’ pyrophosphate 
removal might influence translation as well as cleavage by RNase E. If this is the case, it 
might be expected that more phages will be released into the cultures of ΔrppH mutants, 
as a result of the diminished repression of lytic genes. It would also be interesting to 
investigate if any proportion of the leaderless mRNAs generated by MazF during stationary 
phase have 5’-monophosphorylated ends. It might be that the 5’-hydroxylated, leaderless 
mRNAs generated by MazF are translated sufficiently to allow the expression of cell 
survival/death genes (Giliberti et al., 2012). On the other hand, it is not inconceivable they 
might be 5’ monophosphorylated by a kinase to enhance their translation. After all, the 
polynucleotide kinase used in recombinant DNA technology, is encoded by a bacteriophage 
that infects E. coli (Cameron et al., 1978; Uzan, 2009).  
Genetic approaches are now also required to assess the function of the growing number of 
sRNAs currently being identified in bacteria (Figure 4.10). However, while it is relatively 
straightforward to knock out the genes of sRNAs that do not overlap with other genes, it is 
difficult, and more often than not impossible, to predict how they might function. 
 
78 
 
Chapter 6 
6 Further work and concluding remarks 
By using two sequencing technologies (dRNA-seq and gRNA-seq), the generation of 
nucleotide resolution maps of both the primary and secondary transcriptomes of E. coli 
was achieved. From these maps, sites of transcriptional initiation, stable RNAs, small non-
coding RNAs, leaderless mRNAs, specialized ribosome generation and sites of processing 
and degradation were identified. From this repertoire of features, we detected a 
reasonable overlap with previously identified sites in addition to a large number of novel 
ones. From the data here presented a number of previously undiscovered leaderless 
mRNAs and the identification of sites involved in the formation of specialized ribosomes 
under conditions which both match and diverge from those known to produce such 
specialized machinery has been further established (Chapter 4). These features and the 
sequencing approach used were finally further validated experimentally (Chapter 5). 
There is great interest in the deciphering of the biochemical requirements for recognition 
and action by the repertoire of RNases and other members of the RNA degradation 
machinery present in E. coli and how they act synergistically together. We decided to 
characterise RNase E because, in addition to having many of its substrates being well 
characterised (examples presented in Chapter 3, Chapter 4 and Chapter 5), it is a central 
component of the degradosome (Miczak et al., 1996; Taghbalout and Rothfield, 2007) and 
is essential for cell viability (Apirion and Lassar, 1978; Ono and Kuwano, 1979); all features 
which made it a suitable candidate for characterisation. We initially wanted to characterise 
the contribution of the 5’ monophosphate sensing pocket towards stimulation of cleavage 
during RNase E mediated processing and decay. Total RNA extracted from the wild-type 
strain BW25113 was incubated in vitro either in the absence or presence of the 5’ 
monophosphate sensing deficient mutant NTH-RNase E T170V (Jourdan and Mcdowall, 
2008), which was followed by dRNA-seq analysis. By comparing these two samples, it was 
possible to detect cleavage via direct entry and the evidence indicates that it is widespread 
within the transcriptome (Chapter 4). Furthermore, cleavage sites that were detected in 
vivo and enriched following in vitro T170V incubation were then reconstituted in vitro 
(Chapter 4). These results, in conjunction with those obtained by further analysis of tRNA 
precursor cleavage (Chapter 5) strongly indicate that direct entry is a major pathway for 
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RNA degradation and processing in E. coli, contrary to what is currently understood 
(Mackie, 2013a). 
Indeed, following results presented in Chapter 4 and Chapter 5, a colleague in the 
laboratory, Louise Kime, took the lead in exploring substrate requirements for tRNA 
processing (Kime et al., 2014). She was drawn to study these substrates not only because 
their processing represents one of the main activities of RNase E (Li and Deutscher, 2002; 
Ow and Kushner, 2002) in E. coli and other bacteria (Li et al., 2005), but because the 
localised folding that produces tRNAs limits the formation of alternative secondary 
structures within the precursor (and derivatives) that can complicate the analysis of RNA: 
protein interactions. She focussed on the processing of the polycistronic argX-hisR-leuT-
proM precursor, as it has been the subject of in vivo studies by others (Li and Deutscher, 
2002; Ow and Kushner, 2002), including a recent study that concluded its processing was 
not dependent on the 5’ sensor of RNase E (Garrey and Mackie, 2011). The study confirmed 
that direct entry is central to the processing of tRNA in E. coli and provided the first 
biochemical evidence for natural transcripts that direct entry is indeed mediated by specific 
unpaired RNA regions that are adjacent to, but not contiguous with, segments cleaved by 
RNase E. In addition, the study showed that direct entry at a site on the 5’ side of the 
precursor triggers a series of 5’-monophosphate-dependent cleavages. Consistent with a 
major role for direct entry in tRNA processing, it was also shown by Justin Clarke in the 
group, contrary to a report by others (Garrey et al., 2009), that a 5’-monophosphate is not 
required to ‘activate’ the catalytic step, i.e. efficient cleavage does not have an absolute 
requirement for access to a 5’-monophosphorylated end (Kime et al., 2014). The dissection 
of the requirements for the cleavage of the argX-hisR-leuT-proM precursor made extensive 
use of the same T170V 5’ sensor mutant of NTH-RNase E described here. 
These results, together with the detection of cleavage sites in vivo and their reconstitution 
and enrichment following in vitro incubation of total mRNA with T170V (Chapter 4 and 
Chapter 5), prompted a more extensive study of RNA cleavage by T170V, which was also 
led by Louise Kime and Justin Clarke. To enrich further for sites of direct entry, the total 
RNA used as substrate for in vitro cleavage assays was treated enzymatically to remove 5’-
monophosphorylated ends. Furthermore, a group of processing and degradation sites that 
are highly dependent on RNase E in vivo were identified by making and comparing libraries 
of enriched mRNA isolated from an rnets strain and its congenic wild-type partner at a non-
permissive temperature (Clarke et al., "in preparation"). The pipeline for the follow-on 
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study was the one developed here. This study also confirmed that RNase E cleaves sites by 
direct entry within mRNA, tRNA, rRNA and sRNA transcripts. Thus, contrary to earlier 
expectations (Schoenberg, 2007), the recognition of substrates by direct entry (Joyce and 
Dreyfus, 1998; Leroy et al., 2002; Baker and Mackie, 2003; Bardey et al., 2005; Hammarlof 
and Hughes, 2008) pervades in RNA metabolism in Escherichia coli and likely in many other 
bacterial species that contain homologues of RNase E (Danchin, 2009; Kaberdin et al., 
2011). It will be interesting to investigate whether other RNases that are unrelated to 
RNase E, but have been found to prefer the 5′-monophosphorylated forms of some 
substrates, e.g. Bacillus subtilis RNase Y (Shahbabian et al., 2009), can also cleave a subset 
of transcripts by direct entry. As a result of the work initiated here, it has been concluded 
that the ability of RNase E to interact with 5’-monophosphorylated ends is not required for 
efficient cleavage at a plethora of sites within all classes of RNA within the E. coli 
transcriptome (Clarke et al., "in preparation"). 
Moving forward in the determination of the contribution of other enzymes towards RNA 
degradation and processing, using the methodology described herein, the research group 
has now produced a collection of dRNA-seq maps, which include additional in vitro enzyme 
incubations and the deletion or inactivation of other components of the RNA degradation 
machinery in E. coli, such as, RNase G, RNase III and PNPase. The future aim of having now 
obtained these maps will be to provide a genome wide characterisation of sites that are 
exclusive to each of these enzymes, enabling a better understanding of the biochemical 
requirements for recognition and cleavage. This will help elucidate the interactions that 
occur between the various components of the RNA degradation and processing machinery 
within the cell. 
An additional factor which has been shown to affect RNA processing is the repertoire of 
sRNAs within E. coli. Work presented here detected a vast quantity of novel sRNAs (Chapter 
4). This relates to RNA processing as previously identified sRNAs have been shown to play 
an important role in the regulation of gene expression and mRNA decay (see Section 1.3). 
As explained in Section 1.3, sRNA/RNase E interactions are usually mediated by Hfq. 
Nevertheless, it is uncertain whether RNA destabilisation is a result of the blockage of 
translation and lack of ribosome coverage or the directed action of RNase E on a transcript 
via Hfq. Thus performing dRNA-seq using Hfq deficient strains together with the ΔrppH 
strain could shed further light on which sRNAs are recruited by Hfq and which of these 
stimulate 5’ monophosphate dependent cleavage. Additionally, proteins such as RapZ, 
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which also recruits RNase E and interacts with adapter sRNAs and Hfq in order to direct 
cleavage (Gopel et al., 2013), can also be assessed via dRNA-seq. Nevertheless, the 
possibility remains that RppH is not the only 5’ pyrophosphohydrolase present in E. coli and 
another pyrophosphohydrolase could direct an alternative mechanism for decapping of 5’ 
triphosphorylated RNA. 
An additional serendipitous finding was the detection of MazF-like processing at the 3’ end 
of 16S rRNA, which removes the last 43 nt of this RNA along with the anti-SD sequence 
(Vesper et al., 2011) in order to generate specialized ribosomes which, in turn, transcribe 
leaderless mRNAs (Vesper et al., 2011). This was unexpected as the MazF toxin generates a 
5’-hydroxylated downstream product following cleavage and this ribonuclease is expressed 
only during stress conditions (Nirenberg, 2004; Vesper et al., 2011). These findings were 
unexpected for two reasons. Firstly, we did not knowingly subject the cells to any kind of 
stress. Secondly, if the fragment was generated following MazF cleavage, it would not be 
detected by our approach as we designed the approach to only detect 5’ monophosphate 
or 5’ triphosphate ends depending on how total RNA was treated following extraction. 
Further analysis by our laboratory has indicated that this MazF like processing of 16S rRNA 
could be RNase E dependent. Of further interest was the finding that RhlB has a leaderless 
transcript (Chapter 4); it is possible that the up-regulation of RhlB during stress conditions 
could result in the modification of the architecture of other leaderless and leadered mRNAs 
in order to facilitate ribosome access or their decay, respectively. With this in mind and the 
possibility of a yet unidentified 5’ kinase phosphorylating leaderless mRNAs to facilitate 
their translation by specialised ribosomes a modified mechanism to that previously 
reported (Vesper et al., 2011) is proposed (Figure 6.1); nevertheless, as is the case with 
other models (Lim et al., 2005; Woodall, 2006), it is possible that other factors have a direct 
or indirect input to this model. 
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Figure 6.1 - MazF leaderless mRNA stress transcriptome model. Diagram showing the 
proposed mechanism in which MazF acts, in concert with a group of enzymes, to shift the 
transcriptome of a cell from an exponential growth conformation to a stress response one. 
Following stress induction, the mazEF module is expressed. This results in the degradation 
of anti-toxin MazE by ChpAP (i). MazF is thus released and its activity leads to the 
degradation of the majority of transcripts (ii), furthermore, it removes the 5’ UTR of specific 
transcripts and renders them leaderless (iii); moreover it also removes the 3’ terminal 43 
nts of 16S rRNA which contain the anti-Shine-Dalgarno sequence (iv). These specialized 
ribosomes mediate the selective translation of the leaderless mRNA pool (vi). In addition to 
this, it is proposed that a 5’ kinase phosphorylates the 5’ hydroxylated leaderless mRNAs 
generated by mazF so that they can be readily translated (v) and that the leaderless rhlB 
transcript is responsible for the up regulation of RhlB which aids translation of leaderless 
mRNAs with have a 5’ structure (vii). Adapted from (Vesper et al., 2011). 
The work described here presents a novel approach for the sequencing and mapping of the 
primary and secondary transcriptomes of bacterial genomes. Additionally, this work 
presented a method that allows the number of individual transcript numbers per mRNA per 
cell to be roughly calculated by calibrating the number of reads for each mRNA against that 
of RNAs whose abundance is well characterized (Section 4.3). However, this method is semi 
quantitative and calibrates the transcriptome of a whole population of cells. Even during 
exponential growth in nutrient rich media, gene expression has stochastic fluctuations 
(Elowitz et al., 2002; Davidson and Surette, 2008; Nikolic et al., 2013). This means that it is 
impossible to determine if observations, such as 16S rRNA processing by MazF in 
exponentially growing cultures is a common feature of all cells or a result of a sub-
population expressing stress genes. Recently, the whole transcriptome of a single bacterial 
cell was sequenced (Kang et al., 2011), a feat that was previously restricted to eukaryotic 
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cells. This advance will further aid the investigation of stochastic gene expression and help 
determine whether features observed in a population are an artefact caused by a sub-
population or indeed a common feature across the whole population. 
An additional application for these technologies that is worth mentioning would be their 
use to better understand the interactions that take place between the host and the 
pathogen during infection. This has been recently suggested to be possible by 
simultaneously sequencing and studying the transcriptomes of both organisms; thus being 
able to assess the reaction of the host during infection and that of both host and pathogen 
to treatments at the transcript level (Westermann et al., 2012). This has now evolved 
beyond concept as the authors of the cited article have communicated that this approach 
has now been performed experimentally. Alongside this, a study dually assessing the 
transcriptome of the host and the pathogenic murine cytomegalovirus has also been 
recently published (Juranic Lisnic et al., 2013). 
In addition to E. coli, the combination of improved global and differential RNA-seq 
presented in this thesis was extended to the analysis of Propionibacterium acnes, a major 
contributor to wide-spread human disease, and Streptomyces coelicolor, a model system 
for understanding the control of the production of secondary metabolites, such as 
antibiotics, produced by the streptomycetes. 
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S upplement 
Table S.1 - Transcriptional start sites identified for E. coli. This table presents all the values 
that fell above the upper envelope boundary (Figure 4.2). The first column represents the 
TSS id which was constructed based on the direction of the TSS, forward (FWD) or reverse 
(RVS), followed by the TSS class and the first nucleotide of the TSS. The second and third 
columns represent the left and right limits of the TSS respectively (nucleotide positions 
within 8 nt of each other were classed as belonging to the same TSS) (see Section 
4.2.1).The last column refers to whether or not the TSSs identified showed any overlap with 
experimentally verified TSSs in RegulonDB. See Excel file on attached CD. 
Table S.2 – sRNAs detected. This table presents the sRNAs identified by our approach. The 
columns, left to right, show the sRNA id, flanking genes, flanking genes orientation, sRNA 
left and right positions, sRNA length, elements overlapping the sRNA, databases associated 
with the sRNA and whether the sRNA has been identified by others or is novel. See Excel 
file on attached CD. 
Product 
size 
Sequence Distance between 
TSS and +1 (nt) 
Small 5’- CATGAGGATTACCCATGTCGAAGACAACAAGTTCAACTCTTTATGTATTATGAGC -3’  0 
Small 5’-CATGAGGATTACCCATGTCGAAGACAACAAAGAAGTTCAACTCTTTATGTATTATGAGC-3’ 0 
Large 5’- 
CATGAGGATTACCCATGTCGAAGACAAAGAAGTTCAACTCTTTATGTATTACTAAAGGTTGAC
TTTATTTCACCGGATACGCTTTCGTAAAGCAATAGTAAGCTGATATTCTACCACACTATGAGC-
3’ 
70 
Large 5’-
CATGAGGATTACCCATGTCGAAGACAACAAAGAAGTTCAACTCTTTATGTATTACTAAAGGTT
GACTTTATTTCACCGGATACGCTTTCGTAAAGCAATAGTAAGCTGATATTCTACCACACTATG -
3’ 
70 
Large 5’-
CATGAGGATTACCCatgtCGAAGACAAAGAAGTTCAACTCTTTATGTATTACTAAAGGTTGACTT
TATTTCACCGGATACGCTTTCGTAAAGCAATAGTAAGCTGATATTCTACCACACTATGAGC-3’ 
70 
Table S.3 - rhlB mRNA TSS sequencing results. Sequences of the small and large PCR 
products of rhlB. (Figure 5.1). The sequence for the adaptor ligated during the RLM-RT 
stage is highlighted blue and the +1 site is presented in red. The PCR product size and the 
distance between the +1 and the TSSs are also indicated. 
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